{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:37:36Z","timestamp":1786120656894,"version":"build-2736575974"},"reference-count":479,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02862-7","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:01:23Z","timestamp":1786060883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-translational modifications in metabolic reprogramming: implications for metabolic therapy and immunotherapy in cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Si-Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2862_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","volume":"24","author":"M De Martino","year":"2024","unstructured":"De Martino, M., Rathmell, J. C., Galluzzi, L. & Vanpouille-Box, C. Cancer cell metabolism and antitumour immunity. Nat. Rev. Immunol. 24, 654\u2013669 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2862_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cell.2025.11.031","volume":"189","author":"CN Tzouanas","year":"2026","unstructured":"Tzouanas, C. N. et al. Hepatic adaptation to chronic metabolic stress primes tumorigenesis. Cell 189, 435\u2013460.e28 (2026).","journal-title":"Cell"},{"key":"2862_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee, J. M., Hammar\u00e9n, H. M., Savitski, M. M. & Baek, S. H. Control of protein stability by post-translational modifications. Nat. Commun. 14, 201 (2023).","journal-title":"Nat. Commun."},{"key":"2862_CR4","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s41556-023-01258-x","volume":"25","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins. Nat. Cell Biol. 25, 1676\u20131690 (2023).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat. Metab. 5, 61\u201379 (2023).","journal-title":"Nat. Metab."},{"key":"2862_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405975","volume":"11","author":"F Feng","year":"2024","unstructured":"Feng, F. et al. Lactylome analysis unveils lactylation-dependent mechanisms of stemness remodeling in the liver cancer stem cells. Adv. Sci. 11, e2405975 (2024).","journal-title":"Adv. Sci."},{"key":"2862_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0021-9258(17)46054-6","volume":"2","author":"PA Levene","year":"1906","unstructured":"Levene, P. A. & Alsberg, C. L. The cleavage products of vitellin. J. Biol. Chem. 2, 127\u2013133 (1906).","journal-title":"J. Biol. Chem."},{"key":"2862_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0021-9258(19)52289-X","volume":"216","author":"EH Fischer","year":"1955","unstructured":"Fischer, E. H. & Krebs, E. G. Conversion of phosphorylase b to phosphorylase a in muscle extracts. J. Biol. Chem. 216, 121\u2013132 (1955).","journal-title":"J. Biol. Chem."},{"key":"2862_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0006-3002(56)90273-6","volume":"20","author":"EG Krebs","year":"1956","unstructured":"Krebs, E. G. & Fischer, E. H. The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim. Biophys. Acta 20, 150\u2013157 (1956).","journal-title":"Biochim. Biophys. Acta"},{"key":"2862_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0021-9258(19)77286-X","volume":"231","author":"EG Krebs","year":"1958","unstructured":"Krebs, E. G., Kent, A. B. & Fischer, E. H. The muscle phosphorylase b kinase reaction. J. Biol. Chem. 231, 73\u201383 (1958).","journal-title":"J. Biol. Chem."},{"key":"2862_CR11","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/S0021-9258(18)93463-0","volume":"243","author":"RJ DeLange","year":"1968","unstructured":"DeLange, R. J., Kemp, R. G., Riley, W. D., Cooper, R. A. & Krebs, E. G. Activation of skeletal muscle phosphorylase kinase by adenosine triphosphate and adenosine 3\u2032, 5\u2032-monophosphate. J. Biol. Chem. 243, 2200\u20132208 (1968).","journal-title":"J. Biol. Chem."},{"key":"2862_CR12","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1016\/S0021-9258(19)34204-8","volume":"243","author":"DA Walsh","year":"1968","unstructured":"Walsh, D. A., Perkins, J. P. & Krebs, E. G. An adenosine 3\u2032, 5\u2032-monophosphate-dependant protein kinase from rabbit skeletal muscle. J. Biol. Chem. 243, 3763\u20133765 (1968).","journal-title":"J. Biol. Chem."},{"key":"2862_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1073\/pnas.72.1.11","volume":"72","author":"G Goldstein","year":"1975","unstructured":"Goldstein, G. et al. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc. Natl. Acad. Sci. USA 72, 11\u201315 (1975).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1073\/pnas.74.3.864","volume":"74","author":"IL Goldknopf","year":"1977","unstructured":"Goldknopf, I. L. & Busch, H. Isopeptide linkage between nonhistone and histone 2A polypeptides of chromosomal conjugate-protein A24. Proc. Natl. Acad. Sci. USA 74, 864\u2013868 (1977).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0092-8674(79)90321-0","volume":"17","author":"MF Schmidt","year":"1979","unstructured":"Schmidt, M. F. & Schlesinger, M. J. Fatty acid binding to vesicular stomatitis virus glycoprotein: a new type of post-translational modification of the viral glycoprotein. Cell 17, 813\u2013819 (1979).","journal-title":"Cell"},{"key":"2862_CR16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1073\/pnas.76.4.1687","volume":"76","author":"MF Schmidt","year":"1979","unstructured":"Schmidt, M. F., Bracha, M. & Schlesinger, M. J. Evidence for covalent attachment of fatty acids to Sindbis virus glycoproteins. Proc. Natl. Acad. Sci. USA 76, 1687\u20131691 (1979).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/0006-291X(78)91505-X","volume":"83","author":"Y Kamiya","year":"1978","unstructured":"Kamiya, Y. et al. Structure of rhodotorucine A, a novel lipopeptide, inducing mating tube formation in Rhodosporidiumtoruloides. Biochem. Biophys. Res. Commun. 83, 1077\u20131083 (1978).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2862_CR18","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1016\/S0021-9258(18)68736-8","volume":"263","author":"SL Wolda","year":"1988","unstructured":"Wolda, S. L. & Glomset, J. A. Evidence for modification of lamin B by a product of mevalonic acid. J. Biol. Chem. 263, 5997\u20136000 (1988).","journal-title":"J. Biol. Chem."},{"key":"2862_CR19","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1073\/pnas.79.20.6128","volume":"79","author":"SA Carr","year":"1982","unstructured":"Carr, S. A., Biemann, K., Shoji, S., Parmelee, D. C. & Titani, K. n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle. Proc. Natl. Acad. Sci. USA 79, 6128\u20136131 (1982).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/BF00702349","volume":"13","author":"I Brockhausen","year":"1996","unstructured":"Brockhausen, I. et al. Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates. Glycoconj. J. 13, 849\u2013856 (1996).","journal-title":"Glycoconj. J."},{"key":"2862_CR21","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1016\/S0021-9258(17)43295-9","volume":"259","author":"CR Torres","year":"1984","unstructured":"Torres, C. R. & Hart, G. W. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259, 3308\u20133317 (1984).","journal-title":"J. Biol. Chem."},{"key":"2862_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/0006-291X(92)91747-E","volume":"185","author":"S Kumar","year":"1992","unstructured":"Kumar, S., Tomooka, Y. & Noda, M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem. Biophys. Res. Commun. 185, 1155\u20131161 (1992).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2862_CR23","doi-asserted-by":"publisher","first-page":"28557","DOI":"10.1074\/jbc.272.45.28557","volume":"272","author":"T Kamitani","year":"1997","unstructured":"Kamitani, T., Kito, K., Nguyen, H. P. & Yeh, E. T. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J. Biol. Chem. 272, 28557\u201328562 (1997).","journal-title":"J. Biol. Chem."},{"key":"2862_CR24","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1101\/gad.12.15.2263","volume":"12","author":"F Osaka","year":"1998","unstructured":"Osaka, F. et al. A new NEDD8-ligating system for cullin-4A. Genes Dev 12, 2263\u20132268 (1998).","journal-title":"Genes Dev"},{"key":"2862_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0092-8674(00)81862-0","volume":"88","author":"R Mahajan","year":"1997","unstructured":"Mahajan, R., Delphin, C., Guan, T., Gerace, L. & Melchior, F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97\u2013107 (1997).","journal-title":"Cell"},{"key":"2862_CR26","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1083\/jcb.135.6.1457","volume":"135","author":"MJ Matunis","year":"1996","unstructured":"Matunis, M. J., Coutavas, E. & Blobel, G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457\u20131470 (1996).","journal-title":"J. Cell Biol."},{"key":"2862_CR27","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/sj.emboj.7600205","volume":"23","author":"M Komatsu","year":"2004","unstructured":"Komatsu, M. et al. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J. 23, 1977\u20131986 (2004).","journal-title":"EMBO J."},{"key":"2862_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0167-7799(02)01944-3","volume":"20","author":"M Mann","year":"2002","unstructured":"Mann, M. et al. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 20, 261\u2013268 (2002).","journal-title":"Trends Biotechnol."},{"key":"2862_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature01511","volume":"422","author":"R Aebersold","year":"2003","unstructured":"Aebersold, R. & Mann, M. Mass spectrometry-based proteomics. Nature 422, 198\u2013207 (2003).","journal-title":"Nature"},{"key":"2862_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1073\/pnas.97.1.262","volume":"97","author":"MP Brown","year":"2000","unstructured":"Brown, M. P. et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc. Natl. Acad. Sci. USA 97, 262\u2013267 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI183544","volume":"135","author":"K Liu","year":"2025","unstructured":"Liu, K. et al. 5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis. J. Clin. Investig. 135, e183544 (2025).","journal-title":"J. Clin. Investig."},{"key":"2862_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0092-8674(03)01014-6","volume":"115","author":"DJ Walther","year":"2003","unstructured":"Walther, D. J. et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet \u03b1-granule release. Cell 115, 851\u2013862 (2003).","journal-title":"Cell"},{"key":"2862_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1074\/mcp.M700021-MCP200","volume":"6","author":"Y Chen","year":"2007","unstructured":"Chen, Y. et al. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteomics 6, 812\u2013819 (2007).","journal-title":"Mol. Cell. Proteomics"},{"key":"2862_CR34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2011.08.008","volume":"146","author":"M Tan","year":"2011","unstructured":"Tan, M. et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146, 1016\u20131028 (2011).","journal-title":"Cell"},{"key":"2862_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nchembio.495","volume":"7","author":"Z Zhang","year":"2011","unstructured":"Zhang, Z. et al. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 7, 58\u201363 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"2862_CR36","doi-asserted-by":"crossref","unstructured":"Peng, C. et al. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol. Cell. Proteomics 10, (2011).","DOI":"10.1074\/mcp.M111.012658"},{"key":"2862_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cmet.2014.03.014","volume":"19","author":"M Tan","year":"2014","unstructured":"Tan, M. et al. Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab. 19, 605\u2013617 (2014).","journal-title":"Cell Metab."},{"key":"2862_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nchembio.1497","volume":"10","author":"L Dai","year":"2014","unstructured":"Dai, L. et al. Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark. Nat. Chem. Biol. 10, 365\u2013370 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"2862_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molcel.2016.03.036","volume":"62","author":"Z Xie","year":"2016","unstructured":"Xie, Z. et al. Metabolic regulation of gene expression by histone lysine \u03b2-hydroxybutyrylation. Mol. Cell 62, 194\u2013206 (2016).","journal-title":"Mol. Cell"},{"key":"2862_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"2862_CR41","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.cell.2025.01.043","volume":"188","author":"X He","year":"2025","unstructured":"He, X. et al. Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response. Cell 188, 1858\u20131877.e21 (2025).","journal-title":"Cell"},{"key":"2862_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.chembiol.2020.12.004","volume":"28","author":"R Vannam","year":"2021","unstructured":"Vannam, R. et al. Targeted degradation of the enhancer lysine acetyltransferases CBP and p300. Cell Chem. Biol. 28, 503\u2013514.e12 (2021).","journal-title":"Cell Chem. Biol."},{"key":"2862_CR43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41418-019-0381-y","volume":"27","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1. Cell Death Differ. 27, 695\u2013710 (2020).","journal-title":"Cell Death Differ."},{"key":"2862_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl1584","volume":"10","author":"MU Nguyen","year":"2024","unstructured":"Nguyen, M. U. et al. KAT2A and KAT2B prevent double-stranded RNA accumulation and interferon signaling to maintain intestinal stem cell renewal. Sci. Adv. 10, eadl1584 (2024).","journal-title":"Sci. Adv."},{"key":"2862_CR45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41586-018-0387-5","volume":"560","author":"JB Baell","year":"2018","unstructured":"Baell, J. B. et al. Inhibitors of histone acetyltransferases KAT6A\/B induce senescence and arrest tumour growth. Nature 560, 253\u2013257 (2018).","journal-title":"Nature"},{"key":"2862_CR46","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/s42255-023-00904-w","volume":"5","author":"S Guhathakurta","year":"2023","unstructured":"Guhathakurta, S. et al. COX17 acetylation via MOF-KANSL complex promotes mitochondrial integrity and function. Nat. Metab. 5, 1931\u20131952 (2023).","journal-title":"Nat. Metab."},{"key":"2862_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32\u201342 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"2862_CR48","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35001622","volume":"403","author":"S Imai","year":"2000","unstructured":"Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795\u2013800 (2000).","journal-title":"Nature"},{"key":"2862_CR49","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","volume":"149","author":"P Filippakopoulos","year":"2012","unstructured":"Filippakopoulos, P. et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149, 214\u2013231 (2012).","journal-title":"Cell"},{"key":"2862_CR50","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1016\/j.molcel.2022.09.034","volume":"82","author":"L Song","year":"2022","unstructured":"Song, L. et al. Hotspot mutations in the structured ENL YEATS domain link aberrant transcriptional condensates and cancer. Mol. Cell 82, 4080\u20134098.e12 (2022).","journal-title":"Mol. Cell"},{"key":"2862_CR51","first-page":"364","volume":"36","author":"R Sanchez","year":"2011","unstructured":"Sanchez, R. & Zhou, M.-M. The PHD finger: a versatile epigenome reader. Trends Biochem. Sci. 36, 364\u2013372 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"2862_CR52","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076\u20131080 (2009).","journal-title":"Science"},{"key":"2862_CR53","doi-asserted-by":"publisher","first-page":"188837","DOI":"10.1016\/j.bbcan.2022.188837","volume":"1878","author":"W He","year":"2023","unstructured":"He, W., Li, Q. & Li, X. Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer. Biochim. Biophys. Acta Rev. Cancer 1878, 188837 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"2862_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cmet.2024.10.015","volume":"37","author":"R Zhu","year":"2025","unstructured":"Zhu, R. et al. ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metab. 37, 361\u2013376.e7 (2025).","journal-title":"Cell Metab."},{"key":"2862_CR55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cmet.2024.11.005","volume":"37","author":"R Liu","year":"2025","unstructured":"Liu, R. et al. Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis. Cell Metab. 37, 377\u2013394.e9 (2025).","journal-title":"Cell Metab."},{"key":"2862_CR56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314128121","volume":"121","author":"B Xie","year":"2024","unstructured":"Xie, B. et al. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proc. Natl. Acad. Sci. USA 121, e2314128121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR57","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631, 663\u2013669 (2024).","journal-title":"Nature"},{"key":"2862_CR58","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong, Z. et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell 187, 2375\u20132392.e33 (2024).","journal-title":"Cell"},{"key":"2862_CR59","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41586-024-07992-y","volume":"634","author":"H Li","year":"2024","unstructured":"Li, H. et al. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature 634, 1229\u20131237 (2024).","journal-title":"Nature"},{"key":"2862_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela, C. et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci. Adv. 8, eabi6696 (2022).","journal-title":"Sci. Adv."},{"key":"2862_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110911","volume":"27","author":"R Du","year":"2024","unstructured":"Du, R. et al. Sirtuin 1\/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis. iScience 27, 110911 (2024).","journal-title":"iScience"},{"key":"2862_CR62","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256052","volume":"24","author":"J Jin","year":"2023","unstructured":"Jin, J. et al. SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Rep. 24, e56052 (2023).","journal-title":"EMBO Rep."},{"key":"2862_CR63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2421496121","volume":"121","author":"G Zhai","year":"2024","unstructured":"Zhai, G. et al. DPF2 reads histone lactylation to drive transcription and tumorigenesis. Proc. Natl. Acad. Sci. USA 121, e2421496121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR64","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","volume":"42","author":"H Li","year":"2024","unstructured":"Li, H., Sun, L., Gao, P. & Hu, H. Lactylation in cancer: current understanding and challenges. Cancer Cell 42, 1803\u20131807 (2024).","journal-title":"Cancer Cell"},{"key":"2862_CR65","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.molcel.2018.05.035","volume":"70","author":"H Huang","year":"2018","unstructured":"Huang, H. et al. p300-Mediated lysine 2-hydroxyisobutyrylation regulates glycolysis. Mol. Cell 70, 984 (2018).","journal-title":"Mol. Cell"},{"key":"2862_CR66","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/cr.2017.60","volume":"27","author":"W Xu","year":"2017","unstructured":"Xu, W. et al. Global profiling of crotonylation on non-histone proteins. Cell Res. 27, 946\u2013949 (2017).","journal-title":"Cell Res."},{"key":"2862_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nchembio.2217","volume":"13","author":"Z Kaczmarska","year":"2017","unstructured":"Kaczmarska, Z. et al. Structure of p300 in complex with acyl-CoA variants. Nat. Chem. Biol. 13, 21\u201329 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"2862_CR68","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050967","volume":"22","author":"G Yang","year":"2021","unstructured":"Yang, G. et al. Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesis. EMBO Rep. 22, e50967 (2021).","journal-title":"EMBO Rep."},{"key":"2862_CR69","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41401-022-00945-z","volume":"44","author":"YF Wang","year":"2023","unstructured":"Wang, Y. F. et al. Aspirin modulates succinylation of PGAM1K99 to restrict the glycolysis through NF-\u03baB\/HAT1\/PGAM1 signaling in liver cancer. Acta Pharmacol. Sin. 44, 211\u2013220 (2023).","journal-title":"Acta Pharmacol. Sin."},{"key":"2862_CR70","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10565-024-09897-y","volume":"40","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Antitumorigenic potential of Lactobacillus-derived extracellular vesicles: p53 succinylation and glycolytic reprogramming in intestinal epithelial cells via SIRT5 modulation. Cell Biol. Toxicol. 40, 66 (2024).","journal-title":"Cell Biol. Toxicol."},{"key":"2862_CR71","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.1207861","volume":"334","author":"J Du","year":"2011","unstructured":"Du, J. et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806\u2013809 (2011).","journal-title":"Science"},{"key":"2862_CR72","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Schjoldager","year":"2020","unstructured":"Schjoldager, K. T., Narimatsu, Y., Joshi, H. J. & Clausen, H. Global view of human protein glycosylation pathways and functions. Nat. Rev. Mol. Cell Biol. 21, 729\u2013749 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2862_CR73","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cell.2010.04.012","volume":"141","author":"DF Zielinska","year":"2010","unstructured":"Zielinska, D. F., Gnad, F., Wi\u015bniewski, J. R. & Mann, M. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 141, 897\u2013907 (2010).","journal-title":"Cell"},{"key":"2862_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33806-8","volume":"13","author":"MI Nielsen","year":"2022","unstructured":"Nielsen, M. I. et al. Global mapping of GalNAc-T isoform-specificities and O-glycosylation site-occupancy in a tissue-forming human cell line. Nat. Commun. 13, 6257 (2022).","journal-title":"Nat. Commun."},{"key":"2862_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35067-x","volume":"13","author":"AS Ram\u00edrez","year":"2022","unstructured":"Ram\u00edrez, A. S. et al. Molecular basis for glycan recognition and reaction priming of eukaryotic oligosaccharyltransferase. Nat. Commun. 13, 7296 (2022).","journal-title":"Nat. Commun."},{"key":"2862_CR76","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrm.2017.22","volume":"18","author":"X Yang","year":"2017","unstructured":"Yang, X. & Qian, K. Protein O-GlcNAcylation: emerging mechanisms and functions. Nat. Rev. Mol. Cell Biol. 18, 452\u2013465 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2862_CR77","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2021.01.010","volume":"503","author":"C Lam","year":"2021","unstructured":"Lam, C., Low, J. Y., Tran, P. T. & Wang, H. The hexosamine biosynthetic pathway and cancer: current knowledge and future therapeutic strategies. Cancer Lett. 503, 11\u201318 (2021).","journal-title":"Cancer Lett."},{"key":"2862_CR78","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41568-024-00666-x","volume":"24","author":"EW Tate","year":"2024","unstructured":"Tate, E. W., Soday, L., de la Lastra, A. L., Wang, M. & Lin, H. Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets. Nat. Rev. Cancer 24, 240\u2013260 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"2862_CR79","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0092-8674(90)90294-O","volume":"63","author":"JF Hancock","year":"1990","unstructured":"Hancock, J. F., Paterson, H. & Marshall, C. J. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 63, 133\u2013139 (1990).","journal-title":"Cell"},{"key":"2862_CR80","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41557-019-0237-6","volume":"11","author":"EM Storck","year":"2019","unstructured":"Storck, E. M. et al. Dual chemical probes enable quantitative system-wide analysis of protein prenylation and prenylation dynamics. Nat. Chem. 11, 552\u2013561 (2019).","journal-title":"Nat. Chem."},{"key":"2862_CR81","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1080\/07853890.2023.2193425","volume":"55","author":"H Wang","year":"2023","unstructured":"Wang, H., Xu, X., Wang, J. & Qiao, Y. The role of N-myristoyltransferase 1 in tumour development. Ann. Med. 55, 1422\u20131430 (2023).","journal-title":"Ann. Med."},{"key":"2862_CR82","doi-asserted-by":"publisher","first-page":"e11306","DOI":"10.7554\/eLife.11306","volume":"4","author":"DTS Lin","year":"2015","unstructured":"Lin, D. T. S. & Conibear, E. ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization. eLife 4, e11306 (2015).","journal-title":"eLife"},{"key":"2862_CR83","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41580-024-00700-8","volume":"25","author":"S Mesquita","year":"2024","unstructured":"Mesquita, S. et al. Mechanisms and functions of protein S-acylation. Nat. Rev. Mol. Cell Biol. 25, 488\u2013509 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2862_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1204","volume":"13","author":"C Sampson","year":"2023","unstructured":"Sampson, C. et al. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy. Clin. Transl. Med. 13, e1204 (2023).","journal-title":"Clin. Transl. Med."},{"key":"2862_CR85","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203\u2013229 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"2862_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu, F. et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol. Cancer 23, 148 (2024).","journal-title":"Mol. Cancer"},{"key":"2862_CR87","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41594-024-01221-w","volume":"31","author":"S Rahman","year":"2024","unstructured":"Rahman, S. & Wolberger, C. Breaking the K48-chain: linking ubiquitin beyond protein degradation. Nat. Struct. Mol. Biol. 31, 216\u2013218 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2862_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105343","volume":"108","author":"Q Shi","year":"2024","unstructured":"Shi, Q. et al. Role of TOMM34 on NF-\u03baB activation-related hyperinflammation in severely ill patients with COVID-19 and influenza. EBioMedicine 108, 105343 (2024).","journal-title":"EBioMedicine"},{"key":"2862_CR89","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp6567","volume":"10","author":"A Nespolo","year":"2024","unstructured":"Nespolo, A. et al. USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity. Sci. Adv. 10, eadp6567 (2024).","journal-title":"Sci. Adv."},{"key":"2862_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23219-4","volume":"12","author":"J Hou","year":"2021","unstructured":"Hou, J. et al. USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS. Nat. Commun. 12, 2970 (2021).","journal-title":"Nat. Commun."},{"key":"2862_CR91","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41589-021-00823-5","volume":"17","author":"Y Yu","year":"2021","unstructured":"Yu, Y. et al. K29-linked ubiquitin signaling regulates proteotoxic stress response and cell cycle. Nat. Chem. Biol. 17, 896\u2013905 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"2862_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14286","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Orthogonal ubiquitin transfer identifies ubiquitination substrates under differential control by the two ubiquitin-activating enzymes. Nat. Commun. 8, 14286 (2017).","journal-title":"Nat. Commun."},{"key":"2862_CR93","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S1097-2765(03)00452-0","volume":"12","author":"H Walden","year":"2003","unstructured":"Walden, H. et al. The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1. Mol. Cell 12, 1427\u20131437 (2003).","journal-title":"Mol. Cell"},{"key":"2862_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06979-x","volume":"15","author":"X Lin","year":"2024","unstructured":"Lin, X. et al. UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. Cell Death Dis. 15, 590 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR95","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.devcel.2024.03.018","volume":"59","author":"Y Chang","year":"2024","unstructured":"Chang, Y. et al. The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells. Dev. Cell 59, 1317\u20131332.e5 (2024).","journal-title":"Dev. Cell"},{"key":"2862_CR96","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.molcel.2009.01.011","volume":"33","author":"DT Huang","year":"2009","unstructured":"Huang, D. T. et al. E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol. Cell 33, 483\u2013495 (2009).","journal-title":"Mol. Cell"},{"key":"2862_CR97","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tibs.2022.08.003","volume":"48","author":"E Schulze-Niemand","year":"2023","unstructured":"Schulze-Niemand, E. & Naumann, M. The COP9 signalosome: a versatile regulatory hub of Cullin-RING ligases. Trends Biochem. Sci. 48, 82\u201395 (2023).","journal-title":"Trends Biochem. Sci."},{"key":"2862_CR98","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41586-020-2000-y","volume":"578","author":"K Baek","year":"2020","unstructured":"Baek, K. et al. NEDD8 nucleates a multivalent cullin-RING-UBE2D ubiquitin ligation assembly. Nature 578, 461\u2013466 (2020).","journal-title":"Nature"},{"key":"2862_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04913-5","volume":"22","author":"L Shi","year":"2024","unstructured":"Shi, L. et al. ROS-mediated up-regulation of SAE1 by Helicobacter pylori promotes human gastric tumor genesis and progression. J. Transl. Med. 22, 148 (2024).","journal-title":"J. Transl. Med."},{"key":"2862_CR100","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1111\/cas.16290","volume":"115","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. UBA2 SUMOylates NQO1 and promotes the proliferation of hepatocellular carcinoma by modulating the MAPK pathway. Cancer Sci. 115, 2998\u20133012 (2024).","journal-title":"Cancer Sci."},{"key":"2862_CR101","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158352","volume":"133","author":"J Xiao","year":"2023","unstructured":"Xiao, J. et al. UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer. J. Clin. Investig. 133, e158352 (2023).","journal-title":"J. Clin. Investig."},{"key":"2862_CR102","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.3390\/ijms23148012","volume":"23","author":"N Lara-Ure\u00f1a","year":"2022","unstructured":"Lara-Ure\u00f1a, N., Jafari, V. & Garc\u00eda-Dom\u00ednguez, M. Cancer-associated dysregulation of sumo regulators: proteases and ligases. Int. J. Mol. Sci. 23, 8012 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2862_CR103","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41418-023-01175-4","volume":"30","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1. Cell Death Differ. 30, 1742\u20131756 (2023).","journal-title":"Cell Death Differ."},{"key":"2862_CR104","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","volume":"100","author":"HM Chang","year":"2020","unstructured":"Chang, H. M. & Yeh, E. T. H. SUMO: from bench to bedside. Physiol. Rev. 100, 1599\u20131619 (2020).","journal-title":"Physiol. Rev."},{"key":"2862_CR105","doi-asserted-by":"publisher","first-page":"e012314","DOI":"10.1136\/jitc-2025-012314","volume":"13","author":"W Jia","year":"2025","unstructured":"Jia, W. et al. Hypoxia-induced RCOR2 promotes macrophage M2 polarization and CD8+ T-cell exhaustion by enhancing LIF transcription in hepatocellular carcinoma. J. Immunother. Cancer 13, e012314 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"2862_CR106","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41592-024-02558-2","volume":"22","author":"Z Ye","year":"2025","unstructured":"Ye, Z. et al. Enhanced sensitivity and scalability with a Chip-Tip workflow enables deep single-cell proteomics. Nat. Methods 22, 499\u2013509 (2025).","journal-title":"Nat. Methods"},{"key":"2862_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66031-0","volume":"16","author":"R Cutler","year":"2025","unstructured":"Cutler, R. et al. Mass spectrometry-based profiling of single-cell histone post-translational modifications to dissect chromatin heterogeneity. Nat. Commun. 16, 11100 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR108","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1021\/acs.chemrev.3c00850","volume":"124","author":"Q Gan","year":"2024","unstructured":"Gan, Q. & Fan, C. Orthogonal translation for site-specific installation of post-translational modifications. Chem. Rev. 124, 2805\u20132838 (2024).","journal-title":"Chem. Rev."},{"key":"2862_CR109","doi-asserted-by":"publisher","first-page":"16501","DOI":"10.1021\/acsomega.9b02134","volume":"4","author":"V Eskonen","year":"2019","unstructured":"Eskonen, V., Tong-Ochoa, N., Valtonen, S., Kopra, K. & H\u00e4rm\u00e4, H. Thermal dissociation assay for time-resolved fluorescence detection of protein post-translational modifications. ACS Omega 4, 16501\u201316507 (2019).","journal-title":"ACS Omega"},{"key":"2862_CR110","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1021\/acsnano.3c08623","volume":"18","author":"C Cao","year":"2023","unstructured":"Cao, C. et al. Deep learning-assisted single-molecule detection of protein post-translational modifications with a biological nanopore. ACS Nano 18, 1504\u20131515 (2023).","journal-title":"ACS Nano"},{"key":"2862_CR111","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13046-024-02943-x","volume":"43","author":"Q Meng","year":"2024","unstructured":"Meng, Q. et al. Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression. J. Exp. Clin. Cancer Res. 43, 36 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2862_CR112","doi-asserted-by":"publisher","first-page":"103108","DOI":"10.1016\/j.redox.2024.103108","volume":"71","author":"Q Meng","year":"2024","unstructured":"Meng, Q. et al. Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation. Redox Biol. 71, 103108 (2024).","journal-title":"Redox Biol."},{"key":"2862_CR113","doi-asserted-by":"publisher","first-page":"114736","DOI":"10.1016\/j.bcp.2021.114736","volume":"192","author":"M Sun","year":"2021","unstructured":"Sun, M. et al. PIKE-A promotes glioblastoma growth by driving PPP flux through increasing G6PD expression mediated by phosphorylation of STAT3. Biochem. Pharmacol. 192, 114736 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"2862_CR114","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.apsb.2022.05.019","volume":"13","author":"M Sun","year":"2023","unstructured":"Sun, M. et al. PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD\/ENO1-mediated cell metabolism. Acta Pharm. Sin. B 13, 157\u2013173 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"2862_CR115","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41418-024-01406-2","volume":"32","author":"X Jin","year":"2025","unstructured":"Jin, X. et al. METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma. Cell Death Differ. 32, 466\u2013479 (2025).","journal-title":"Cell Death Differ."},{"key":"2862_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15819-3","volume":"11","author":"J Cheng","year":"2020","unstructured":"Cheng, J. et al. TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K\/AKT pathway and PPP metabolism. Nat. Commun. 11, 1880 (2020).","journal-title":"Nat. Commun."},{"key":"2862_CR117","doi-asserted-by":"crossref","unstructured":"Stacpoole, P. W. Therapeutic targeting of the pyruvate dehydrogenase complex\/pyruvate dehydrogenase kinase (PDC\/PDK) axis in cancer. J. Natl. Cancer Inst. 109, (2017).","DOI":"10.1093\/jnci\/djx071"},{"key":"2862_CR118","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/procel\/pwae052","volume":"16","author":"Z Jiang","year":"2025","unstructured":"Jiang, Z. et al. PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation-mediated gene expression. Protein Cell 16, 49\u201363 (2025).","journal-title":"Protein Cell"},{"key":"2862_CR119","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.molcel.2019.08.006","volume":"76","author":"X Qian","year":"2019","unstructured":"Qian, X. et al. PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1. Mol. Cell 76, 516\u2013527.e7 (2019).","journal-title":"Mol. Cell"},{"key":"2862_CR120","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.molcel.2016.02.009","volume":"61","author":"X Li","year":"2016","unstructured":"Li, X. et al. Mitochondria-translocated PGK1 functions as a protein kinase to coordinate glycolysis and the TCA cycle in tumorigenesis. Mol. Cell 61, 705\u2013719 (2016).","journal-title":"Mol. Cell"},{"key":"2862_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06544-6","volume":"15","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis. Cell Death Dis. 15, 170 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13601-8","volume":"11","author":"H Nie","year":"2020","unstructured":"Nie, H. et al. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat. Commun. 11, 36 (2020).","journal-title":"Nat. Commun."},{"key":"2862_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51232-w","volume":"15","author":"Z Guo","year":"2024","unstructured":"Guo, Z. et al. Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating glycolysis and the TCA cycle. Nat. Commun. 15, 6915 (2024).","journal-title":"Nat. Commun."},{"key":"2862_CR124","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41589-024-01683-5","volume":"21","author":"Z Peng","year":"2025","unstructured":"Peng, Z. et al. Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer. Nat. Chem. Biol. 21, 59\u201370 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"2862_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44772-8","volume":"15","author":"T Chen","year":"2024","unstructured":"Chen, T. et al. AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis. Nat. Commun. 15, 686 (2024).","journal-title":"Nat. Commun."},{"key":"2862_CR126","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41388-024-03035-y","volume":"43","author":"Z Zhou","year":"2024","unstructured":"Zhou, Z. et al. ULK1-dependent phosphorylation of PKM2 antagonizes O-GlcNAcylation and regulates the Warburg effect in breast cancer. Oncogene 43, 1769\u20131778 (2024).","journal-title":"Oncogene"},{"key":"2862_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03212-3","volume":"11","author":"R Zhang","year":"2020","unstructured":"Zhang, R. et al. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma. Cell Death Dis. 11, 1036 (2020).","journal-title":"Cell Death Dis."},{"key":"2862_CR128","doi-asserted-by":"publisher","first-page":"102458","DOI":"10.1016\/j.redox.2022.102458","volume":"56","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q. et al. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biol. 56, 102458 (2022).","journal-title":"Redox Biol."},{"key":"2862_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02009-8","volume":"23","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment. Mol. Cancer 23, 94 (2024).","journal-title":"Mol. Cancer"},{"key":"2862_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07235-y","volume":"15","author":"J Pan","year":"2024","unstructured":"Pan, J. et al. Correction: CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation. Cell Death Dis. 15, 885 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21960-4","volume":"12","author":"S Coassolo","year":"2021","unstructured":"Coassolo, S. et al. Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation. Nat. Commun. 12, 1718 (2021).","journal-title":"Nat. Commun."},{"key":"2862_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06898-x","volume":"15","author":"L Peng","year":"2024","unstructured":"Peng, L. et al. PRMT1 promotes Warburg effect by regulating the PKM2\/PKM1 ratio in non-small cell lung cancer. Cell Death Dis. 15, 504 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR133","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/hep.30923","volume":"71","author":"TL Wong","year":"2020","unstructured":"Wong, T. L. et al. CRAF methylation by PRMT6 regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation. Hepatology 71, 1279\u20131296 (2020).","journal-title":"Hepatology"},{"key":"2862_CR134","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41388-021-02071-2","volume":"41","author":"S Yu","year":"2022","unstructured":"Yu, S., Zang, W., Qiu, Y., Liao, L. & Zheng, X. Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis. Oncogene 41, 46\u201356 (2022).","journal-title":"Oncogene"},{"key":"2862_CR135","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/s44318-024-00110-8","volume":"43","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer. EMBO J. 43, 2368\u20132396 (2024).","journal-title":"EMBO J."},{"key":"2862_CR136","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.245","volume":"4","author":"F Xie","year":"2023","unstructured":"Xie, F. et al. PRMT5 promotes ovarian cancer growth through enhancing the Warburg effect by methylating ENO1. MedComm 4, e245 (2023).","journal-title":"MedComm"},{"key":"2862_CR137","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2408354121","volume":"121","author":"Q Zhu","year":"2024","unstructured":"Zhu, Q. et al. O-GlcNAcylation of enolase 1 serves as a dual regulator of aerobic glycolysis and immune evasion in colorectal cancer. Proc. Natl. Acad. Sci. USA 121, e2408354121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR138","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13046-025-03543-z","volume":"44","author":"Y Fang","year":"2025","unstructured":"Fang, Y. et al. SENP1 drives glycolysis and cisplatin resistance in gastric cancer via desumoylating ENO1. J. Exp. Clin. Cancer Res. 44, 285 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2862_CR139","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13046-020-01681-0","volume":"39","author":"X Li","year":"2020","unstructured":"Li, X. et al. Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer. J. Exp. Clin. Cancer Res. 39, 172 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2862_CR140","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gpb.2022.02.004","volume":"21","author":"OK Kwon","year":"2023","unstructured":"Kwon, O. K. et al. LDHA desuccinylase sirtuin 5 as a novel cancer metastatic stimulator in aggressive prostate cancer. Genom. Proteomics Bioinform. 21, 177\u2013189 (2023).","journal-title":"Genom. Proteomics Bioinform."},{"key":"2862_CR141","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s41418-023-01157-6","volume":"30","author":"L Shi","year":"2023","unstructured":"Shi, L. et al. LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer. Cell Death Differ. 30, 1517\u20131532 (2023).","journal-title":"Cell Death Differ."},{"key":"2862_CR142","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/neuonc\/noae040","volume":"26","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. HIF1\u03b1\/ATF3 partake in PGK1 K191\/K192 succinylation by modulating P4HA1\/succinate signaling in glioblastoma. Neuro-Oncol 26, 1405\u20131420 (2024).","journal-title":"Neuro-Oncol"},{"key":"2862_CR143","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13046-024-03152-2","volume":"43","author":"L Huangfu","year":"2024","unstructured":"Huangfu, L. et al. The deubiquitinase USP15 drives malignant progression of gastric cancer through glucose metabolism remodeling. J. Exp. Clin. Cancer Res. 43, 235 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2862_CR144","doi-asserted-by":"publisher","first-page":"12850","DOI":"10.18632\/aging.206108","volume":"16","author":"C Hu","year":"2024","unstructured":"Hu, C. et al. USP4 promotes PTC progression by stabilizing LDHA and activating the MAPK and AKT signaling pathway. Aging 16, 12850\u201312865 (2024).","journal-title":"Aging"},{"key":"2862_CR145","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1038\/s41388-024-03157-3","volume":"43","author":"X Sun","year":"2024","unstructured":"Sun, X. et al. The tumor suppressor Parkin exerts anticancer effects through regulating mitochondrial GAPDH activity. Oncogene 43, 3215\u20133226 (2024).","journal-title":"Oncogene"},{"key":"2862_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22163-7","volume":"12","author":"X Shangguan","year":"2021","unstructured":"Shangguan, X. et al. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nat. Commun. 12, 1812 (2021).","journal-title":"Nat. Commun."},{"key":"2862_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04727-7","volume":"13","author":"J Tantai","year":"2022","unstructured":"Tantai, J., Pan, X., Chen, Y., Shen, Y. & Ji, C. TRIM46 activates AKT\/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells. Cell Death Dis. 13, 285 (2022).","journal-title":"Cell Death Dis."},{"key":"2862_CR148","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/cac2.12351","volume":"42","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability. Cancer Commun. 42, 1008\u20131027 (2022).","journal-title":"Cancer Commun."},{"key":"2862_CR149","doi-asserted-by":"publisher","first-page":"101966","DOI":"10.1016\/j.xcrm.2025.101966","volume":"6","author":"X Jiang","year":"2025","unstructured":"Jiang, X. et al. KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC. Cell Rep. Med. 6, 101966 (2025).","journal-title":"Cell Rep. Med."},{"key":"2862_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07137-z","volume":"15","author":"T Xia","year":"2024","unstructured":"Xia, T., Meng, L., Xu, G., Sun, H. & Chen, H. TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth. Cell Death Dis. 15, 740 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR151","doi-asserted-by":"publisher","first-page":"217105","DOI":"10.1016\/j.canlet.2024.217105","volume":"598","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. Inhibition of KIF20A enhances the immunotherapeutic effect of hepatocellular carcinoma by enhancing c-Myc ubiquitination. Cancer Lett. 598, 217105 (2024).","journal-title":"Cancer Lett."},{"key":"2862_CR152","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.7150\/thno.102730","volume":"15","author":"Z Deng","year":"2025","unstructured":"Deng, Z. et al. DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization. Theranostics 15, 2375\u20132392 (2025).","journal-title":"Theranostics"},{"key":"2862_CR153","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41392-024-02034-5","volume":"9","author":"Y Lin","year":"2024","unstructured":"Lin, Y. et al. Phosphorylation determines the glucose metabolism reprogramming and tumor-promoting activity of sine oculis homeobox 1. Signal Transduct. Target. Ther. 9, 337 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR154","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/gutjnl-2019-319616","volume":"69","author":"S Ling","year":"2020","unstructured":"Ling, S. et al. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1\u03b1\/USP22 positive feedback loop upon TP53 inactivation. Gut 69, 1322\u20131334 (2020).","journal-title":"Gut"},{"key":"2862_CR155","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3350\/cmh.2024.0236","volume":"30","author":"R Zhang","year":"2024","unstructured":"Zhang, R. et al. UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL. Clin. Mol. Hepatol. 30, 771\u2013792 (2024).","journal-title":"Clin. Mol. Hepatol."},{"key":"2862_CR156","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315348121","volume":"121","author":"Y Nan","year":"2024","unstructured":"Nan, Y. et al. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition. Proc. Natl. Acad. Sci. USA 121, e2315348121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li, F. et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol. Cancer 23, 90 (2024).","journal-title":"Mol. Cancer"},{"key":"2862_CR158","doi-asserted-by":"publisher","first-page":"216285","DOI":"10.1016\/j.canlet.2023.216285","volume":"567","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. NUSAP1-LDHA-glycolysis-lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma. Cancer Lett. 567, 216285 (2023).","journal-title":"Cancer Lett."},{"key":"2862_CR159","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1038\/s43587-025-01023-9","volume":"5","author":"B Guan","year":"2025","unstructured":"Guan, B. et al. Peritumoral colonic epithelial cell-derived GDF15 sustains colorectal cancer via regulation of glycolysis and histone lactylation. Nat. Aging 5, 2449\u20132465 (2025).","journal-title":"Nat. Aging"},{"key":"2862_CR160","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41418-024-01436-w","volume":"32","author":"H Hong","year":"2025","unstructured":"Hong, H. et al. ABCF1-K430-Lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathway. Cell Death Differ. 32, 613\u2013631 (2025).","journal-title":"Cell Death Differ."},{"key":"2862_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2019.09.015","volume":"469","author":"Y Tong","year":"2020","unstructured":"Tong, Y. et al. KAT2A succinyltransferase activity-mediated 14-3-3\u03b6 upregulation promotes \u03b2-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells. Cancer Lett. 469, 1\u201310 (2020).","journal-title":"Cancer Lett."},{"key":"2862_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04403-0","volume":"21","author":"W Duan","year":"2023","unstructured":"Duan, W. et al. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis. J. Transl. Med. 21, 547 (2023).","journal-title":"J. Transl. Med."},{"key":"2862_CR163","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell 187, 294\u2013311.e21 (2024).","journal-title":"Cell"},{"key":"2862_CR164","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.cmet.2024.07.011","volume":"36","author":"G Li","year":"2024","unstructured":"Li, G. et al. Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. Cell Metab. 36, 1696\u20131710.e10 (2024).","journal-title":"Cell Metab."},{"key":"2862_CR165","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415530","volume":"12","author":"B Zheng","year":"2025","unstructured":"Zheng, B. et al. High sugar induced RCC2 lactylation drives breast cancer tumorigenicity through upregulating MAD2L1. Adv. Sci. 12, e2415530 (2025).","journal-title":"Adv. Sci."},{"key":"2862_CR166","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41392-025-02458-7","volume":"10","author":"J Wu","year":"2025","unstructured":"Wu, J. et al. KAT2A-driven succinylation of SRSF11 enforces spliceosome-mediated RAD52 splicing to promote homologous recombination and radioresistance in hepatocellular carcinoma. Signal Transduct. Target. Ther. 10, 364 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR167","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41418-024-01315-4","volume":"31","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. The OGT-c-Myc-PDK2 axis rewires the TCA cycle and promotes colorectal tumor growth. Cell Death Differ. 31, 1157\u20131169 (2024).","journal-title":"Cell Death Differ."},{"key":"2862_CR168","doi-asserted-by":"publisher","first-page":"9830","DOI":"10.7150\/thno.45161","volume":"10","author":"Y Chu","year":"2020","unstructured":"Chu, Y. et al. O-GlcNAcylation of SIX1 enhances its stability and promotes hepatocellular carcinoma proliferation. Theranostics 10, 9830\u20139842 (2020).","journal-title":"Theranostics"},{"key":"2862_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56633-z","volume":"16","author":"N Zhang","year":"2025","unstructured":"Zhang, N. et al. FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis to restrain endometrial malignancy. Nat. Commun. 16, 1274 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07313-1","volume":"15","author":"L Lin","year":"2024","unstructured":"Lin, L. et al. CARM1-mediated OGT arginine methylation promotes non-small cell lung cancer glycolysis by stabilizing OGT. Cell Death Dis. 15, 927 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR171","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1038\/s41388-021-02058-z","volume":"40","author":"R Liu","year":"2021","unstructured":"Liu, R. et al. O-GlcNAc modified-TIP60\/KAT5 is required for PCK1 deficiency-induced HCC metastasis. Oncogene 40, 6707\u20136719 (2021).","journal-title":"Oncogene"},{"key":"2862_CR172","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13046-019-1029-y","volume":"38","author":"L Tuo","year":"2019","unstructured":"Tuo, L. et al. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK\/p27Kip1 axis. J. Exp. Clin. Cancer Res. 38, 50 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2862_CR173","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144703","volume":"131","author":"J Xiang","year":"2021","unstructured":"Xiang, J. et al. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. J. Clin. Investig. 131, e144703 (2021). 144703.","journal-title":"J. Clin. Investig."},{"key":"2862_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1756-1","volume":"10","author":"C Shan","year":"2019","unstructured":"Shan, C. et al. 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK\/HDAC10\/G6PD axis. Cell Death Dis. 10, 525 (2019).","journal-title":"Cell Death Dis."},{"key":"2862_CR175","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2020.03.007","volume":"478","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation. Cancer Lett. 478, 82\u201392 (2020).","journal-title":"Cancer Lett."},{"key":"2862_CR176","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1158\/0008-5472.CAN-20-3044","volume":"81","author":"L Bi","year":"2021","unstructured":"Bi, L. et al. HDAC11 regulates glycolysis through the LKB1\/AMPK signaling pathway to maintain hepatocellular carcinoma stemness. Cancer Res. 81, 2015\u20132028 (2021).","journal-title":"Cancer Res."},{"key":"2862_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07482-7","volume":"16","author":"CH Ding","year":"2025","unstructured":"Ding, C. H. et al. PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma. Cell Death Dis. 16, 158 (2025).","journal-title":"Cell Death Dis."},{"key":"2862_CR178","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","volume":"84","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. H3K18 lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res. 84, 3589\u20133601 (2024).","journal-title":"Cancer Res."},{"key":"2862_CR179","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"ZW Huang","year":"2023","unstructured":"Huang, Z. W. et al. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct. Target. Ther. 8, 391 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR180","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.7150\/thno.105947","volume":"15","author":"Z Ma","year":"2025","unstructured":"Ma, Z. et al. Histone lactylation-driven B7-H3 expression promotes tumor immune evasion. Theranostics 15, 2338\u20132359 (2025).","journal-title":"Theranostics"},{"key":"2862_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06921-1","volume":"15","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC. Cell Death Dis. 15, 613 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR182","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.7150\/ijbs.58295","volume":"17","author":"W Xu","year":"2021","unstructured":"Xu, W. et al. Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte\/macrophage infiltration into the clear cell renal cell carcinoma microenvironment. Int. J. Biol. Sci. 17, 2205\u20132222 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"2862_CR183","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","volume":"34","author":"D Guo","year":"2022","unstructured":"Guo, D. et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1. Cell Metab. 34, 1312\u20131324.e6 (2022).","journal-title":"Cell Metab."},{"key":"2862_CR184","doi-asserted-by":"publisher","first-page":"1189953","DOI":"10.3389\/fimmu.2023.1189953","volume":"14","author":"J Lin","year":"2023","unstructured":"Lin, J. et al. Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion. Front. Immunol. 14, 1189953 (2023).","journal-title":"Front. Immunol."},{"key":"2862_CR185","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1111\/cas.16204","volume":"115","author":"Y Tong","year":"2024","unstructured":"Tong, Y. et al. Hexokinase 2 nonmetabolic function-mediated phosphorylation of I\u03baB\u03b1 enhances pancreatic ductal adenocarcinoma progression. Cancer Sci. 115, 2673\u20132685 (2024).","journal-title":"Cancer Sci."},{"key":"2862_CR186","doi-asserted-by":"publisher","first-page":"114686","DOI":"10.1016\/j.celrep.2024.114686","volume":"43","author":"R Wang","year":"2024","unstructured":"Wang, R. et al. H3K9 lactylation in malignant cells facilitates CD8+ T cell dysfunction and poor immunotherapy response. Cell Rep. 43, 114686 (2024).","journal-title":"Cell Rep."},{"key":"2862_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06589-7","volume":"15","author":"HR Zhang","year":"2024","unstructured":"Zhang, H. R. et al. The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell Death Dis. 15, 244 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR188","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406333","volume":"11","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Lactylated apolipoprotein C-II induces immunotherapy resistance by promoting extracellular lipolysis. Adv. Sci. 11, e2406333 (2024).","journal-title":"Adv. Sci."},{"key":"2862_CR189","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","volume":"580","author":"D Xu","year":"2020","unstructured":"Xu, D. et al. The gluconeogenic enzyme PCK1 phosphorylates INSIG1\/2 for lipogenesis. Nature 580, 530\u2013535 (2020).","journal-title":"Nature"},{"key":"2862_CR190","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2020.09.040","volume":"142","author":"F Shao","year":"2021","unstructured":"Shao, F. et al. Association of phosphoenolpyruvate carboxykinase 1 protein kinase activity-dependent sterol regulatory element-binding protein 1 activation with prognosis of oesophageal carcinoma. Eur. J. Cancer 142, 123\u2013131 (2021).","journal-title":"Eur. J. Cancer"},{"key":"2862_CR191","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1158\/2159-8290.CD-24-0866","volume":"15","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. PIN1 prolyl isomerase promotes initiation and progression of bladder cancer through the SREBP2-mediated cholesterol biosynthesis pathway. Cancer Discov. 15, 633\u2013655 (2025).","journal-title":"Cancer Discov."},{"key":"2862_CR192","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.molcel.2021.02.009","volume":"81","author":"W Tan","year":"2021","unstructured":"Tan, W. et al. Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylation. Mol. Cell 81, 1890\u20131904.e7 (2021).","journal-title":"Mol. Cell"},{"key":"2862_CR193","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.cell.2017.10.037","volume":"171","author":"G Lee","year":"2017","unstructured":"Lee, G. et al. Post-transcriptional regulation of de novo lipogenesis by mTORC1-S6K1-SRPK2 signaling. Cell 171, 1545\u20131558.e18 (2017).","journal-title":"Cell"},{"key":"2862_CR194","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.molcel.2025.02.024","volume":"85","author":"X He","year":"2025","unstructured":"He, X. et al. PI3K\u03b2 functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth. Mol. Cell 85, 1411\u20131425.e8 (2025).","journal-title":"Mol. Cell"},{"key":"2862_CR195","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2402674121","volume":"121","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. O-GlcNAcylation of ATP-citrate lyase couples glucose supply to lipogenesis for rapid tumor cell proliferation. Proc. Natl. Acad. Sci. USA 121, e2402674121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR196","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s12964-024-01926-x","volume":"22","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. USP11 promotes lipogenesis and tumorigenesis by regulating SREBF1 stability in hepatocellular carcinoma. Cell Commun. Signal. 22, 550 (2024).","journal-title":"Cell Commun. Signal."},{"key":"2862_CR197","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-022-02583-z","volume":"42","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability. J. Exp. Clin. Cancer Res. 42, 34 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2862_CR198","doi-asserted-by":"publisher","first-page":"154302","DOI":"10.1016\/j.metabol.2020.154302","volume":"110","author":"KH Noh","year":"2020","unstructured":"Noh, K. H. et al. Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression. Metabolism 110, 154302 (2020).","journal-title":"Metabolism"},{"key":"2862_CR199","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29846-9","volume":"13","author":"Z Ning","year":"2022","unstructured":"Ning, Z. et al. USP22 regulates lipidome accumulation by stabilizing PPAR\u03b3 in hepatocellular carcinoma. Nat. Commun. 13, 2187 (2022).","journal-title":"Nat. Commun."},{"key":"2862_CR200","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/hep.32045","volume":"74","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD. Hepatology 74, 2508\u20132525 (2021).","journal-title":"Hepatology"},{"key":"2862_CR201","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02195-5","volume":"23","author":"Y Mo","year":"2024","unstructured":"Mo, Y. et al. ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. Mol. Cancer 23, 274 (2024).","journal-title":"Mol. Cancer"},{"key":"2862_CR202","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41375-023-02130-5","volume":"38","author":"B Liu","year":"2024","unstructured":"Liu, B. et al. Targeting ZDHHC21\/FASN axis for the treatment of diffuse large B-cell lymphoma. Leukemia 38, 351\u2013364 (2024).","journal-title":"Leukemia"},{"key":"2862_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06929-7","volume":"15","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer. Cell Death Dis. 15, 537 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR204","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jhep.2025.02.045","volume":"83","author":"S Zhou","year":"2025","unstructured":"Zhou, S. et al. eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma. J. Hepatol. 83, 712\u2013728 (2025).","journal-title":"J. Hepatol."},{"key":"2862_CR205","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41422-020-00443-z","volume":"31","author":"P Xie","year":"2021","unstructured":"Xie, P. et al. Neddylation of PTEN regulates its nuclear import and promotes tumor development. Cell Res. 31, 291\u2013311 (2021).","journal-title":"Cell Res."},{"key":"2862_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26180-4","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat. Commun. 12, 5872 (2021).","journal-title":"Nat. Commun."},{"key":"2862_CR207","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s42255-024-01047-2","volume":"6","author":"Y Meng","year":"2024","unstructured":"Meng, Y. et al. Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet-mitochondria tethering to enhance \u03b2-oxidation and tumor cell proliferation. Nat. Metab. 6, 1092\u20131107 (2024).","journal-title":"Nat. Metab."},{"key":"2862_CR208","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108065","volume":"40","author":"F Liu","year":"2021","unstructured":"Liu, F. et al. PKM2-TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability. EMBO J. 40, e108065 (2021).","journal-title":"EMBO J."},{"key":"2862_CR209","doi-asserted-by":"crossref","unstructured":"Zeng, Y. et al. TRAF3 loss protects glioblastoma cells from lipid peroxidation and immune elimination via dysregulated lipid metabolism. J. Clin. Investig. 135, (2025).","DOI":"10.1172\/JCI178550"},{"key":"2862_CR210","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13046-024-03154-0","volume":"43","author":"J Shan","year":"2024","unstructured":"Shan, J. et al. Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPAR\u03b3-driven lipid biosynthesis via regulating lipidome metabolic reprogramming. J. Exp. Clin. Cancer Res. 43, 227 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2862_CR211","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2412473122","volume":"122","author":"X Qian","year":"2025","unstructured":"Qian, X. et al. Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPAR\u03b1 hydroxylation in an iron-dependent manner. Proc. Natl. Acad. Sci. USA 122, e2412473122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR212","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55785-8","volume":"16","author":"M Yang","year":"2025","unstructured":"Yang, M. et al. S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism. Nat. Commun. 16, 509 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR213","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1182\/blood-2016-09-736892","volume":"129","author":"S Gayle","year":"2017","unstructured":"Gayle, S. et al. Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. Blood 129, 1768\u20131778 (2017).","journal-title":"Blood"},{"key":"2862_CR214","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3324\/haematol.2019.222729","volume":"105","author":"CB de Campos","year":"2020","unstructured":"de Campos, C. B. et al. Identification of PIKfyve kinase as a target in multiple myeloma. Haematologica 105, 1641\u20131649 (2020).","journal-title":"Haematologica"},{"key":"2862_CR215","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41586-025-08917-z","volume":"642","author":"C Cheng","year":"2025","unstructured":"Cheng, C. et al. Targeting PIKfyve-driven lipid metabolism in pancreatic cancer. Nature 642, 776\u2013784 (2025).","journal-title":"Nature"},{"key":"2862_CR216","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41556-022-01009-4","volume":"24","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Fructose-1,6-bisphosphatase 1 functions as a protein phosphatase to dephosphorylate histone H3 and suppresses PPAR\u03b1-regulated gene transcription and tumour growth. Nat. Cell Biol. 24, 1655\u20131665 (2022).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41810-9","volume":"14","author":"T Nguyen","year":"2023","unstructured":"Nguyen, T. et al. Author Correction: histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer. Nat. Commun. 14, 6022 (2023).","journal-title":"Nat. Commun."},{"key":"2862_CR218","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06181-5","volume":"14","author":"C Jiang","year":"2023","unstructured":"Jiang, C. et al. Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer. Cell Death Dis. 14, 653 (2023).","journal-title":"Cell Death Dis."},{"key":"2862_CR219","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308422","volume":"11","author":"L Yuan","year":"2024","unstructured":"Yuan, L. et al. Fatty acid oxidation supports lymph node metastasis of cervical cancer via acetyl-CoA-mediated stemness. Adv. Sci. 11, e2308422 (2024).","journal-title":"Adv. Sci."},{"key":"2862_CR220","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42170-0","volume":"14","author":"DW Jeong","year":"2023","unstructured":"Jeong, D. W. et al. Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma. Nat. Commun. 14, 6370 (2023).","journal-title":"Nat. Commun."},{"key":"2862_CR221","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57099-9","volume":"16","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. Lipogenic enzyme FASN promotes mutant p53 accumulation and gain-of-function through palmitoylation. Nat. Commun. 16, 1762 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR222","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.cmet.2024.04.018","volume":"36","author":"F Peng","year":"2024","unstructured":"Peng, F. et al. Oncogenic fatty acid oxidation senses circadian disruption in sleep-deficiency-enhanced tumorigenesis. Cell Metab. 36, 1598\u20131618.e11 (2024).","journal-title":"Cell Metab."},{"key":"2862_CR223","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1073\/pnas.78.5.2869","volume":"78","author":"MH Park","year":"1981","unstructured":"Park, M. H., Cooper, H. L. & Folk, J. E. Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc. Natl. Acad. Sci. USA 78, 2869\u20132873 (1981).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR224","doi-asserted-by":"publisher","first-page":"18710","DOI":"10.1074\/jbc.TM118.003341","volume":"293","author":"MH Park","year":"2018","unstructured":"Park, M. H. & Wolff, E. C. Hypusine, a polyamine-derived amino acid critical for eukaryotic translation. J. Biol. Chem. 293, 18710\u201318718 (2018).","journal-title":"J. Biol. Chem."},{"key":"2862_CR225","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/hep.27067","volume":"60","author":"M Lesurtel","year":"2014","unstructured":"Lesurtel, M. & Clavien, P. A. Platelet-derived serotonin: translational implications for liver regeneration. Hepatology 60, 30 (2014).","journal-title":"Hepatology"},{"key":"2862_CR226","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","volume":"132","author":"MD Gershon","year":"2007","unstructured":"Gershon, M. D. & Tack, J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132, 397\u2013414 (2007).","journal-title":"Gastroenterology"},{"key":"2862_CR227","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36708-5","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang, K. et al. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma. Nat. Commun. 14, 1011 (2023).","journal-title":"Nat. Commun."},{"key":"2862_CR228","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41422-018-0021-y","volume":"28","author":"T Han","year":"2018","unstructured":"Han, T. et al. Phosphorylation of glutaminase by PKC\u03b5 is essential for its enzymatic activity and critically contributes to tumorigenesis. Cell Res. 28, 655\u2013669 (2018).","journal-title":"Cell Res."},{"key":"2862_CR229","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ccell.2019.05.002","volume":"35","author":"M Li","year":"2019","unstructured":"Li, M. et al. Non-oncogene addiction to SIRT3 plays a critical role in lymphomagenesis. Cancer Cell 35, 916\u2013931.e9 (2019).","journal-title":"Cancer Cell"},{"key":"2862_CR230","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02951-4","volume":"9","author":"YQ Wang","year":"2018","unstructured":"Wang, Y. Q. et al. Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner. Nat. Commun. 9, 545 (2018).","journal-title":"Nat. Commun."},{"key":"2862_CR231","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41392-023-01367-x","volume":"8","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis. Signal Transduct. Target. Ther. 8, 159 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49087-2","volume":"15","author":"L Luo","year":"2024","unstructured":"Luo, L. et al. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. Nat. Commun. 15, 4790 (2024).","journal-title":"Nat. Commun."},{"key":"2862_CR233","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1158\/0008-5472.CAN-23-2266","volume":"84","author":"T Yamamoto","year":"2024","unstructured":"Yamamoto, T. et al. PRMT1 sustains de novo fatty acid synthesis by methylating PHGDH to drive chemoresistance in triple-negative breast cancer. Cancer Res. 84, 1065\u20131083 (2024).","journal-title":"Cancer Res."},{"key":"2862_CR234","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-024-08335-7","volume":"638","author":"G Doglioni","year":"2025","unstructured":"Doglioni, G. et al. Aspartate signalling drives lung metastasis via alternative translation. Nature 638, 244\u2013250 (2025).","journal-title":"Nature"},{"key":"2862_CR235","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1016\/j.molcel.2025.10.002","volume":"85","author":"MA Nengroo","year":"2025","unstructured":"Nengroo, M. A. et al. Accumulation of succinate suppresses de novo purine synthesis through succinylation-mediated control of the mitochondrial folate cycle. Mol. Cell 85, 4215\u20134228.e9 (2025).","journal-title":"Mol. Cell"},{"key":"2862_CR236","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/s41589-022-01085-5","volume":"18","author":"Q Zhu","year":"2022","unstructured":"Zhu, Q. et al. O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1. Nat. Chem. Biol. 18, 1087\u20131095 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"2862_CR237","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2021.06.045","volume":"161","author":"T Hu","year":"2021","unstructured":"Hu, T. et al. Metabolic rewiring by loss of Sirt5 promotes Kras-induced pancreatic cancer progression. Gastroenterology 161, 1584\u20131600 (2021).","journal-title":"Gastroenterology"},{"key":"2862_CR238","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.molcel.2021.04.002","volume":"81","author":"Y Tong","year":"2021","unstructured":"Tong, Y. et al. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells. Mol. Cell 81, 2303\u20132316.e8 (2021).","journal-title":"Mol. Cell"},{"key":"2862_CR239","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jhep.2024.05.034","volume":"81","author":"Y Lao","year":"2024","unstructured":"Lao, Y. et al. Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma. J. Hepatol. 81, 847\u2013861 (2024).","journal-title":"J. Hepatol."},{"key":"2862_CR240","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/s41556-022-00985-x","volume":"24","author":"S Verma","year":"2022","unstructured":"Verma, S. et al. NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling. Nat. Cell Biol. 24, 1422\u20131432 (2022).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR241","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu, Y. et al. Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv. Sci. 11, e2401399 (2024).","journal-title":"Adv. Sci."},{"key":"2862_CR242","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416467","volume":"12","author":"C Zheng","year":"2025","unstructured":"Zheng, C. et al. ACAT1-mediated ME2 acetylation drives chemoresistance in ovarian cancer by linking glutaminolysis to lactate production. Adv. Sci. 12, e2416467 (2025).","journal-title":"Adv. Sci."},{"key":"2862_CR243","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06050-1","volume":"14","author":"C Yang","year":"2023","unstructured":"Yang, C. et al. Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment. Cell Death Dis. 14, 525 (2023).","journal-title":"Cell Death Dis."},{"key":"2862_CR244","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34747-y","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis. Nat. Commun. 13, 7215 (2022).","journal-title":"Nat. Commun."},{"key":"2862_CR245","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cmet.2025.02.008","volume":"37","author":"N Wang","year":"2025","unstructured":"Wang, N. et al. Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism. Cell Metab. 37, 1381\u20131399.e1389 (2025).","journal-title":"Cell Metab."},{"key":"2862_CR246","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1158\/2643-3230.BCD-22-0162","volume":"4","author":"S Nakanishi","year":"2023","unstructured":"Nakanishi, S. et al. The polyamine-hypusine circuit controls an oncogenic translational program essential for malignant conversion in MYC-driven lymphoma. Blood Cancer Discov. 4, 294\u2013317 (2023).","journal-title":"Blood Cancer Discov."},{"key":"2862_CR247","doi-asserted-by":"publisher","first-page":"216120","DOI":"10.1016\/j.canlet.2023.216120","volume":"559","author":"S Coni","year":"2023","unstructured":"Coni, S. et al. Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation. Cancer Lett. 559, 216120 (2023).","journal-title":"Cancer Lett."},{"key":"2862_CR248","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03174-6","volume":"11","author":"S Coni","year":"2020","unstructured":"Coni, S. et al. Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation. Cell Death Dis. 11, 1045 (2020).","journal-title":"Cell Death Dis."},{"key":"2862_CR249","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","volume":"24","author":"H Li","year":"2022","unstructured":"Li, H. et al. YAP\/TAZ drives cell proliferation and tumor growth via a polyamine-eIF5A hypusination-LSD1 axis. Nat. Cell Biol. 24, 373\u2013383 (2022).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR250","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020107480","volume":"40","author":"J Shao","year":"2021","unstructured":"Shao, J. et al. Cytosolic GDH1 degradation restricts protein synthesis to sustain tumor cell survival following amino acid deprivation. EMBO J. 40, e107480 (2021).","journal-title":"EMBO J."},{"key":"2862_CR251","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/neuonc\/noae222","volume":"27","author":"R Yang","year":"2024","unstructured":"Yang, R. et al. Glutamate dehydrogenase 1-catalytic glutaminolysis feedback activates EGFR\/PI3K\/AKT pathway and reprograms glioblastoma metabolism. Neuro-Oncol. 27, 668\u2013681 (2024).","journal-title":"Neuro-Oncol."},{"key":"2862_CR252","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/neuonc\/noac231","volume":"25","author":"R Yang","year":"2023","unstructured":"Yang, R. et al. Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression. Neuro-Oncol. 25, 635\u2013647 (2023).","journal-title":"Neuro-Oncol."},{"key":"2862_CR253","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-024-01928-8","volume":"9","author":"T Zhang","year":"2024","unstructured":"Zhang, T. et al. Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation. Signal Transduct. Target. Ther. 9, 216 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR254","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112675","volume":"42","author":"K Hu","year":"2023","unstructured":"Hu, K. et al. Glutamate dehydrogenase1 supports HIF-1\u03b1 stability to promote colorectal tumorigenesis under hypoxia. EMBO J. 42, e112675 (2023).","journal-title":"EMBO J."},{"key":"2862_CR255","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf4291","volume":"7","author":"J Zhao","year":"2021","unstructured":"Zhao, J. et al. Structural insights into the recognition of histone H3Q5 serotonylation by WDR5. Sci. Adv. 7, eabf4291 (2021).","journal-title":"Sci. Adv."},{"key":"2862_CR256","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jhep.2024.12.038","volume":"83","author":"R Dong","year":"2025","unstructured":"Dong, R. et al. TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway. J. Hepatol. 83, 105\u2013118 (2025).","journal-title":"J. Hepatol."},{"key":"2862_CR257","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41586-024-07751-z","volume":"632","author":"HC Chen","year":"2024","unstructured":"Chen, H. C. et al. Histone serotonylation regulates ependymoma tumorigenesis. Nature 632, 903\u2013910 (2024).","journal-title":"Nature"},{"key":"2862_CR258","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016742118","volume":"118","author":"S Zhao","year":"2021","unstructured":"Zhao, S. et al. Histone H3Q5 serotonylation stabilizes H3K4 methylation and potentiates its readout. Proc. Natl. Acad. Sci. USA 118, e2016742118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR259","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41586-019-1024-7","volume":"567","author":"LA Farrelly","year":"2019","unstructured":"Farrelly, L. A. et al. Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3. Nature 567, 535\u2013539 (2019).","journal-title":"Nature"},{"key":"2862_CR260","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1053\/j.gastro.2025.01.240","volume":"168","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. The Moonlighting function of glutaminase 2 promotes immune evasion of pancreatic ductal adenocarcinoma by tubulin tyrosine ligase-like 1-mediated Yes1 associated transcriptional regulator glutamylation. Gastroenterology 168, 1137\u20131152 (2025).","journal-title":"Gastroenterology"},{"key":"2862_CR261","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186648","volume":"135","author":"W Wei","year":"2025","unstructured":"Wei, W. et al. Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signaling. J. Clin. Investig. 135, e186648 (2025).","journal-title":"J. Clin. Investig."},{"key":"2862_CR262","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8188","volume":"13","author":"MA Schneider","year":"2021","unstructured":"Schneider, M. A. et al. Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models. Sci. Transl. Med. 13, eabc8188 (2021).","journal-title":"Sci. Transl. Med."},{"key":"2862_CR263","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12964-023-01096-2","volume":"21","author":"H Yu","year":"2023","unstructured":"Yu, H., Qu, T., Yang, J. & Dai, Q. Serotonin acts through YAP to promote cell proliferation: mechanism and implication in colorectal cancer progression. Cell Commun. Signal. 21, 75 (2023).","journal-title":"Cell Commun. Signal."},{"key":"2862_CR264","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-021-01971-1","volume":"40","author":"D Ye","year":"2021","unstructured":"Ye, D. et al. Targeting SERT promotes tryptophan metabolism: mechanisms and implications in colon cancer treatment. J. Exp. Clin. Cancer Res. 40, 173 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2862_CR265","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02031-w","volume":"23","author":"BS Park","year":"2024","unstructured":"Park, B. S. et al. Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma. Mol. Cancer 23, 136 (2024).","journal-title":"Mol. Cancer"},{"key":"2862_CR266","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2025.01.024","volume":"188","author":"JL Schneider","year":"2025","unstructured":"Schneider, J. L. et al. GUK1 activation is a metabolic liability in lung cancer. Cell 188, 1248\u20131264.e23 (2025).","journal-title":"Cell"},{"key":"2862_CR267","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41594-024-01473-6","volume":"32","author":"J Tao","year":"2025","unstructured":"Tao, J. et al. ERK-USP9X-coupled regulation of thymidine kinase 1 promotes both its enzyme activity-dependent and its enzyme activity-independent functions for tumor growth. Nat. Struct. Mol. Biol. 32, 853\u2013863 (2025).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2862_CR268","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41556-022-01061-0","volume":"25","author":"T Liu","year":"2023","unstructured":"Liu, T. et al. Nucleus-exported CLOCK acetylates PRPS to promote de novo nucleotide synthesis and liver tumour growth. Nat. Cell Biol. 25, 273\u2013284 (2023).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR269","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240902","volume":"222","author":"W Qin","year":"2025","unstructured":"Qin, W. et al. PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion. J. Exp. Med. 222, e20240902 (2025).","journal-title":"J. Exp. Med."},{"key":"2862_CR270","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41556-025-01627-8","volume":"27","author":"Y Duan","year":"2025","unstructured":"Duan, Y. et al. ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion. Nat. Cell Biol. 27, 668\u2013682 (2025).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR271","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07219-y","volume":"15","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. PRMT1-mediated methylation of ME2 promotes hepatocellular carcinoma growth by inhibiting ubiquitination. Cell Death Dis. 15, 814 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR272","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1038\/s41388-021-01785-7","volume":"40","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. Arginine and lysine methylation of MRPS23 promotes breast cancer metastasis through regulating OXPHOS. Oncogene 40, 3548\u20133563 (2021).","journal-title":"Oncogene"},{"key":"2862_CR273","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood-2023-189396","volume":"142","author":"X Shao","year":"2023","unstructured":"Shao, X. et al. The palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML. Blood 142, 365\u2013381 (2023).","journal-title":"Blood"},{"key":"2862_CR274","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1158\/0008-5472.CAN-23-3829","volume":"84","author":"WJ Hsu","year":"2024","unstructured":"Hsu, W. J. et al. Arginine methylation of DDX3 by PRMT1 mediates mitochondrial homeostasis to promote breast cancer metastasis. Cancer Res. 84, 3023\u20133043 (2024).","journal-title":"Cancer Res."},{"key":"2862_CR275","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s44318-024-00101-9","volume":"43","author":"W Yan","year":"2024","unstructured":"Yan, W. et al. SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression. EMBO J. 43, 2337\u20132367 (2024).","journal-title":"EMBO J."},{"key":"2862_CR276","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.molcel.2019.09.019","volume":"76","author":"X Qian","year":"2019","unstructured":"Qian, X. et al. KDM3A senses oxygen availability to regulate PGC-1\u03b1-mediated mitochondrial biogenesis. Mol. Cell 76, 885\u2013895.e7 (2019).","journal-title":"Mol. Cell"},{"key":"2862_CR277","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s11427-021-2048-2","volume":"65","author":"X Pei","year":"2022","unstructured":"Pei, X. et al. Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth. Sci. China Life Sci. 65, 2017\u20132030 (2022).","journal-title":"Sci. China Life Sci."},{"key":"2862_CR278","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41418-023-01240-y","volume":"31","author":"P Teng","year":"2024","unstructured":"Teng, P. et al. SIRT5-mediated ME2 desuccinylation promotes cancer growth by enhancing mitochondrial respiration. Cell Death Differ. 31, 65\u201377 (2024).","journal-title":"Cell Death Differ."},{"key":"2862_CR279","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.molcel.2023.11.042","volume":"84","author":"W Ma","year":"2024","unstructured":"Ma, W. et al. OXCT1 functions as a succinyltransferase, contributing to hepatocellular carcinoma via succinylating LACTB. Mol. Cell 84, 538\u2013551.e7 (2024).","journal-title":"Mol. Cell"},{"key":"2862_CR280","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.molcel.2024.12.025","volume":"85","author":"D Guo","year":"2025","unstructured":"Guo, D. et al. OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth. Mol. Cell 85, 843\u2013856.e6 (2025).","journal-title":"Mol. Cell"},{"key":"2862_CR281","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49675-2","volume":"15","author":"SY Huang","year":"2024","unstructured":"Huang, S. Y. et al. PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma. Nat. Commun. 15, 5300 (2024).","journal-title":"Nat. Commun."},{"key":"2862_CR282","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1080\/15548627.2023.2246356","volume":"19","author":"W Sun","year":"2023","unstructured":"Sun, W., Jia, M., Feng, Y. & Cheng, X. Lactate is a bridge linking glycolysis and autophagy through lactylation. Autophagy 19, 3240\u20133241 (2023).","journal-title":"Autophagy"},{"key":"2862_CR283","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li, W. et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy 20, 114\u2013130 (2024).","journal-title":"Autophagy"},{"key":"2862_CR284","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1080\/15548627.2023.2287932","volume":"20","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. Deacetylation of ATG7 drives the induction of macroautophagy and LC3-associated microautophagy. Autophagy 20, 1134\u20131146 (2024).","journal-title":"Autophagy"},{"key":"2862_CR285","doi-asserted-by":"publisher","first-page":"156041","DOI":"10.1016\/j.metabol.2024.156041","volume":"162","author":"J Yang","year":"2025","unstructured":"Yang, J. et al. Inhibition of ACSS2 triggers glycolysis inhibition and nuclear translocation to activate SIRT1\/ATG5\/ATG2B deacetylation axis, promoting autophagy and reducing malignancy and chemoresistance in ovarian cancer. Metabolism 162, 156041 (2025).","journal-title":"Metabolism"},{"key":"2862_CR286","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1080\/15548627.2023.2246357","volume":"19","author":"LA Rowland","year":"2023","unstructured":"Rowland, L. A. & Czech, M. P. Fatty acid availability controls autophagy and associated cell functions. Autophagy 19, 3242\u20133243 (2023).","journal-title":"Autophagy"},{"key":"2862_CR287","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07168-6","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN. Cell Death Dis. 15, 788 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR288","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1080\/15548627.2024.2386915","volume":"20","author":"F Wei","year":"2024","unstructured":"Wei, F. et al. ZDHHC7-mediated S-palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation. Autophagy 20, 2719\u20132737 (2024).","journal-title":"Autophagy"},{"key":"2862_CR289","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/15548627.2024.2410619","volume":"21","author":"L Chen","year":"2025","unstructured":"Chen, L. et al. USP13 facilitates a ferroptosis-to-autophagy switch by activation of the NFE2L2\/NRF2-SQSTM1\/p62-KEAP1 axis dependent on the KRAS signaling pathway. Autophagy 21, 565\u2013582 (2025).","journal-title":"Autophagy"},{"key":"2862_CR290","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s41589-024-01825-9","volume":"21","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. ADSL promotes autophagy and tumor growth through fumarate-mediated Beclin1 dimethylation. Nat. Chem. Biol. 21, 894\u2013905 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"2862_CR291","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1158\/0008-5472.CAN-23-1167","volume":"84","author":"L Li","year":"2024","unstructured":"Li, L. et al. WNK1 interaction with KEAP1 promotes NRF2 stabilization to enhance the oxidative stress response in hepatocellular carcinoma. Cancer Res. 84, 2776\u20132791 (2024).","journal-title":"Cancer Res."},{"key":"2862_CR292","doi-asserted-by":"publisher","first-page":"101149","DOI":"10.1016\/j.redox.2019.101149","volume":"22","author":"L Tian","year":"2019","unstructured":"Tian, L. et al. aPKC\u03b9 promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1. Redox Biol. 22, 101149 (2019).","journal-title":"Redox Biol."},{"key":"2862_CR293","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204438","volume":"10","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. DDRGK1 enhances osteosarcoma chemoresistance via inhibiting KEAP1-mediated NRF2 ubiquitination. Adv. Sci. 10, e2204438 (2023).","journal-title":"Adv. Sci."},{"key":"2862_CR294","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/s41388-023-02717-3","volume":"42","author":"J Wei","year":"2023","unstructured":"Wei, J. et al. TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1. Oncogene 42, 2103\u20132112 (2023).","journal-title":"Oncogene"},{"key":"2862_CR295","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14190-2","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nat. Commun. 11, 348 (2020).","journal-title":"Nat. Commun."},{"key":"2862_CR296","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.redox.2022.102344","volume":"53","author":"W Liu","year":"2022","unstructured":"Liu, W. et al. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS\/AMPK\/mTOR\/autophagy signaling. Redox Biol. 53, 102344 (2022).","journal-title":"Redox Biol."},{"key":"2862_CR297","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/hep.30978","volume":"71","author":"Q Sun","year":"2020","unstructured":"Sun, Q. et al. Loss of xanthine oxidoreductase potentiates propagation of hepatocellular carcinoma stem cells. Hepatology 71, 2033\u20132049 (2020).","journal-title":"Hepatology"},{"key":"2862_CR298","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1080\/15548627.2024.2374692","volume":"20","author":"EJ Choi","year":"2024","unstructured":"Choi, E. J. et al. Metabolic stress induces a double-positive feedback loop between AMPK and SQSTM1\/p62 conferring dual activation of AMPK and NFE2L2\/NRF2 to synergize antioxidant defense. Autophagy 20, 2490\u20132510 (2024).","journal-title":"Autophagy"},{"key":"2862_CR299","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li, D. et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene 42, 83\u201398 (2023).","journal-title":"Oncogene"},{"key":"2862_CR300","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41556-025-01610-3","volume":"27","author":"Y Fan","year":"2025","unstructured":"Fan, Y. et al. PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer. Nat. Cell Biol. 27, 641\u2013653 (2025).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR301","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56344-5","volume":"16","author":"B Huang","year":"2025","unstructured":"Huang, B. et al. Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis. Nat. Commun. 16, 867 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR302","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s43018-025-00937-y","volume":"6","author":"L Zhou","year":"2025","unstructured":"Zhou, L. et al. Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity. Nat. Cancer 6, 768\u2013785 (2025).","journal-title":"Nat. Cancer"},{"key":"2862_CR303","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408845","volume":"12","author":"Z Yang","year":"2025","unstructured":"Yang, Z. et al. Lactylation of HDAC1 confers resistance to ferroptosis in colorectal cancer. Adv. Sci. 12, e2408845 (2025).","journal-title":"Adv. Sci."},{"key":"2862_CR304","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.cell.2025.03.019","volume":"188","author":"JS Yang","year":"2025","unstructured":"Yang, J. S. et al. ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1. Cell 188, 2569\u20132585.e20 (2025).","journal-title":"Cell"},{"key":"2862_CR305","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.molcel.2023.05.011","volume":"83","author":"Y Han","year":"2023","unstructured":"Han, Y. et al. IL-1\u03b2-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance. Mol. Cell 83, 1887\u20131902.e8 (2023).","journal-title":"Mol. Cell"},{"key":"2862_CR306","doi-asserted-by":"publisher","first-page":"103479","DOI":"10.1016\/j.redox.2024.103479","volume":"79","author":"K Niu","year":"2025","unstructured":"Niu, K. et al. NSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC-dependent glutathione synthesis. Redox Biol. 79, 103479 (2025).","journal-title":"Redox Biol."},{"key":"2862_CR307","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","volume":"79","author":"T Liu","year":"2019","unstructured":"Liu, T., Jiang, L., Tavana, O. & Gu, W. The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11. Cancer Res. 79, 1913\u20131924 (2019).","journal-title":"Cancer Res."},{"key":"2862_CR308","doi-asserted-by":"publisher","first-page":"217232","DOI":"10.1016\/j.canlet.2024.217232","volume":"604","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer. Cancer Lett. 604, 217232 (2024).","journal-title":"Cancer Lett."},{"key":"2862_CR309","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","volume":"31","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation. Cell Death Differ. 31, 53\u201364 (2024).","journal-title":"Cell Death Differ."},{"key":"2862_CR310","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen, Q. et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ. 30, 137\u2013151 (2023).","journal-title":"Cell Death Differ."},{"key":"2862_CR311","doi-asserted-by":"publisher","first-page":"2302953","DOI":"10.1002\/advs.202302953","volume":"10","author":"J Tang","year":"2023","unstructured":"Tang, J. et al. Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT. Adv. Sci. 10, 2302953 (2023).","journal-title":"Adv. Sci."},{"key":"2862_CR312","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41556-025-01722-w","volume":"27","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis. Nat. Cell Biol. 27, 1288\u20131300 (2025).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR313","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41416-023-02562-x","volume":"130","author":"Z Cui","year":"2024","unstructured":"Cui, Z. et al. TRIM21\/USP15 balances ACSL4 stability and the imatinib resistance of gastrointestinal stromal tumors. Br. J. Cancer 130, 526\u2013541 (2024).","journal-title":"Br. J. Cancer"},{"key":"2862_CR314","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41421-025-00829-6","volume":"11","author":"G Shan","year":"2025","unstructured":"Shan, G. et al. Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma. Cell Discov. 11, 81 (2025).","journal-title":"Cell Discov."},{"key":"2862_CR315","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13045-025-01680-8","volume":"18","author":"Y Ding","year":"2025","unstructured":"Ding, Y. et al. Disruption of the sorcin\u2012PAX5 protein\u2012protein interaction induces ferroptosis by promoting the FBXL12-mediated ubiquitination of ALDH1A1 in pancreatic cancer. J. Hematol. Oncol. 18, 27 (2025).","journal-title":"J. Hematol. Oncol."},{"key":"2862_CR316","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","volume":"83","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Mol. Cell 83, 4352\u20134369.e8 (2023).","journal-title":"Mol. Cell"},{"key":"2862_CR317","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02203-8","volume":"24","author":"C Can","year":"2025","unstructured":"Can, C. et al. Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity. Mol. Cancer 24, 4 (2025).","journal-title":"Mol. Cancer"},{"key":"2862_CR318","doi-asserted-by":"publisher","first-page":"103182","DOI":"10.1016\/j.redox.2024.103182","volume":"73","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells. Redox Biol. 73, 103182 (2024).","journal-title":"Redox Biol."},{"key":"2862_CR319","doi-asserted-by":"publisher","first-page":"101154","DOI":"10.1016\/j.drup.2024.101154","volume":"77","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer. Drug Resist. Updat. 77, 101154 (2024).","journal-title":"Drug Resist. Updat."},{"key":"2862_CR320","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06902-4","volume":"15","author":"M Mansuer","year":"2024","unstructured":"Mansuer, M., Zhou, L., Wang, C., Gao, L. & Jiang, Y. Erianin induces ferroptosis in GSCs via REST\/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance. Cell Death Dis. 15, 522 (2024).","journal-title":"Cell Death Dis."},{"key":"2862_CR321","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022).","journal-title":"Science"},{"key":"2862_CR322","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer. Nat. Commun. 14, 6523 (2023).","journal-title":"Nat. Commun."},{"key":"2862_CR323","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","volume":"43","author":"Z Yang","year":"2025","unstructured":"Yang, Z. et al. Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis. Cancer Cell 43, 937\u2013954.e9 (2025).","journal-title":"Cancer Cell"},{"key":"2862_CR324","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41423-024-01247-6","volume":"22","author":"Z Cui","year":"2025","unstructured":"Cui, Z. et al. MYO1F regulates T-cell activation and glycolytic metabolism by promoting the acetylation of GAPDH. Cell. Mol. Immunol. 22, 176\u2013190 (2025).","journal-title":"Cell. Mol. Immunol."},{"key":"2862_CR325","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.molcel.2023.12.015","volume":"84","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. A GAPDH serotonylation system couples CD8+ T cell glycolytic metabolism to antitumor immunity. Mol. Cell 84, 760\u2013775.e7 (2024).","journal-title":"Mol. Cell"},{"key":"2862_CR326","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04622-1","volume":"13","author":"F Sun","year":"2022","unstructured":"Sun, F. et al. SUMOylation of PDPK1 is required to maintain glycolysis-dependent CD4 T-cell homeostasis. Cell Death Dis. 13, 181 (2022).","journal-title":"Cell Death Dis."},{"key":"2862_CR327","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/0008-5472.CAN-21-4052","volume":"82","author":"S Chowdhury","year":"2022","unstructured":"Chowdhury, S. et al. Intracellular Acetyl CoA potentiates the therapeutic efficacy of antitumor CD8+ T cells. Cancer Res. 82, 2640\u20132655 (2022).","journal-title":"Cancer Res."},{"key":"2862_CR328","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231820","volume":"221","author":"I Kaymak","year":"2024","unstructured":"Kaymak, I. et al. ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses. J. Exp. Med. 221, e20231820 (2024).","journal-title":"J. Exp. Med."},{"key":"2862_CR329","doi-asserted-by":"publisher","DOI":"10.1172\/JCI155224","volume":"132","author":"Z Wu","year":"2022","unstructured":"Wu, Z. et al. SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8+ T cells. J. Clin. Investig. 132, e155224 (2022).","journal-title":"J. Clin. Investig."},{"key":"2862_CR330","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176586","volume":"134","author":"J He","year":"2024","unstructured":"He, J. et al. Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses. J. Clin. Investig. 134, e176586 (2024).","journal-title":"J. Clin. Investig."},{"key":"2862_CR331","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41556-017-0002-2","volume":"20","author":"R Ma","year":"2018","unstructured":"Ma, R. et al. A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells. Nat. Cell Biol. 20, 21\u201327 (2018).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR332","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41556-019-0440-0","volume":"22","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Ketogenesis-generated \u03b2-hydroxybutyrate is an epigenetic regulator of CD8+ T-cell memory development. Nat. Cell Biol. 22, 18\u201325 (2020).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR333","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41590-024-01985-9","volume":"25","author":"D Raychaudhuri","year":"2024","unstructured":"Raychaudhuri, D. et al. Histone lactylation drives CD8+ T cell metabolism and function. Nat. Immunol. 25, 2140\u20132151 (2024).","journal-title":"Nat. Immunol."},{"key":"2862_CR334","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24619-2","volume":"12","author":"J He","year":"2021","unstructured":"He, J. et al. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development. Nat. Commun. 12, 4371 (2021).","journal-title":"Nat. Commun."},{"key":"2862_CR335","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.molcel.2019.06.008","volume":"75","author":"T Wang","year":"2019","unstructured":"Wang, T. et al. SENP1-Sirt3 signaling controls mitochondrial protein acetylation and metabolism. Mol. Cell 75, 823\u2013834.e5 (2019).","journal-title":"Mol. Cell"},{"key":"2862_CR336","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccell.2024.11.003","volume":"43","author":"Y Qiu","year":"2025","unstructured":"Qiu, Y. et al. Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity. Cancer Cell 43, 103\u2013121.e8 (2025).","journal-title":"Cancer Cell"},{"key":"2862_CR337","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj3020","volume":"387","author":"S Ma","year":"2025","unstructured":"Ma, S. et al. Nutrient-driven histone code determines exhausted CD8+ T cell fates. Science 387, eadj3020 (2025).","journal-title":"Science"},{"key":"2862_CR338","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144318","volume":"131","author":"F Wang","year":"2021","unstructured":"Wang, F. et al. ZFP91 disturbs metabolic fitness and antitumor activity of tumor-infiltrating T cells. J. Clin. Investig. 131, e144318 (2021).","journal-title":"J. Clin. Investig."},{"key":"2862_CR339","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.7150\/thno.95748","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. CBX4 suppresses CD8+ T cell antitumor immunity by reprogramming glycolytic metabolism. Theranostics 14, 3793\u20133809 (2024).","journal-title":"Theranostics"},{"key":"2862_CR340","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s42255-023-00855-2","volume":"5","author":"E Minogue","year":"2023","unstructured":"Minogue, E. et al. Glutarate regulates T cell metabolism and anti-tumour immunity. Nat. Metab. 5, 1747\u20131764 (2023).","journal-title":"Nat. Metab."},{"key":"2862_CR341","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41418-025-01490-y","volume":"32","author":"Z Hu","year":"2025","unstructured":"Hu, Z. et al. SIRT7 regulates T-cell antitumor immunity through modulation BCAA and fatty acid metabolism. Cell Death Differ. 32, 1777\u20131790 (2025).","journal-title":"Cell Death Differ."},{"key":"2862_CR342","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adp7302","volume":"9","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. Sci. Immunol. 9, eadp7302 (2024).","journal-title":"Sci. Immunol."},{"key":"2862_CR343","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-018-0597-x","volume":"562","author":"M Song","year":"2018","unstructured":"Song, M. et al. IRE1\u03b1\u2013XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature 562, 423\u2013428 (2018).","journal-title":"Nature"},{"key":"2862_CR344","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","volume":"585","author":"Y Bian","year":"2020","unstructured":"Bian, Y. et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature 585, 277\u2013282 (2020).","journal-title":"Nature"},{"key":"2862_CR345","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.cmet.2025.11.016","volume":"38","author":"J Xiao","year":"2026","unstructured":"Xiao, J. et al. Uridine depletion impairs CD8+ T cell antitumor activity through N-glycosylation. Cell Metab. 38, 616\u2013632.e8 (2026).","journal-title":"Cell Metab."},{"key":"2862_CR346","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature13418","volume":"510","author":"B Bingol","year":"2014","unstructured":"Bingol, B. et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 510, 370\u2013375 (2014).","journal-title":"Nature"},{"key":"2862_CR347","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","volume":"638","author":"H Ikeda","year":"2025","unstructured":"Ikeda, H. et al. Immune evasion through mitochondrial transfer in the tumour microenvironment. Nature 638, 225\u2013236 (2025).","journal-title":"Nature"},{"key":"2862_CR348","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44779-1","volume":"15","author":"C Zhou","year":"2024","unstructured":"Zhou, C. et al. Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death. Nat. Commun. 15, 499 (2024).","journal-title":"Nat. Commun."},{"key":"2862_CR349","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong, J. et al. Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol. Cell 82, 1660\u20131677.e10 (2022).","journal-title":"Mol. Cell"},{"key":"2862_CR350","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403629","volume":"11","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Increases in 4-acetaminobutyric acid generated by phosphomevalonate kinase suppress CD8+ T cell activation and allow tumor immune escape. Adv. Sci. 11, e2403629 (2024).","journal-title":"Adv. Sci."},{"key":"2862_CR351","doi-asserted-by":"publisher","first-page":"115128","DOI":"10.1016\/j.celrep.2024.115128","volume":"44","author":"G Li","year":"2025","unstructured":"Li, G., Wen, Z. & Xiong, S. Microenvironmental \u03b2-TrCP negates amino acid transport to trigger CD8+ T cell exhaustion in human non-small cell lung cancer. Cell Rep. 44, 115128 (2025).","journal-title":"Cell Rep."},{"key":"2862_CR352","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2024.01.005","volume":"36","author":"C Hu","year":"2024","unstructured":"Hu, C. et al. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells. Cell Metab. 36, 630\u2013647.e8 (2024).","journal-title":"Cell Metab."},{"key":"2862_CR353","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50138-x","volume":"15","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer. Nat. Commun. 15, 5851 (2024).","journal-title":"Nat. Commun."},{"key":"2862_CR354","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ado3485","volume":"10","author":"J Liang","year":"2025","unstructured":"Liang, J. et al. Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma. Sci. Immunol. 10, eado3485 (2025).","journal-title":"Sci. Immunol."},{"key":"2862_CR355","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13046-023-02890-z","volume":"42","author":"J Lin","year":"2023","unstructured":"Lin, J. et al. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma. J. Exp. Clin. Cancer Res.42, 339 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2862_CR356","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s12276-024-01214-1","volume":"56","author":"DH Kim","year":"2024","unstructured":"Kim, D. H. et al. Glutamine-derived aspartate is required for eIF5A hypusination-mediated translation of HIF-1\u03b1 to induce the polarization of tumor-associated macrophages. Exp. Mol. Med. 56, 1123\u20131136 (2024).","journal-title":"Exp. Mol. Med."},{"key":"2862_CR357","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","volume":"57","author":"A De Leo","year":"2024","unstructured":"De Leo, A. et al. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity 57, 1105\u20131123.e8 (2024).","journal-title":"Immunity"},{"key":"2862_CR358","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/2159-8290.CD-24-1056","volume":"15","author":"A Ugolini","year":"2025","unstructured":"Ugolini, A. et al. Functional reprogramming of neutrophils within the brain tumor microenvironment by hypoxia-driven histone lactylation. Cancer Discov. 15, 1270\u20131296 (2025).","journal-title":"Cancer Discov."},{"key":"2862_CR359","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/cac2.12607","volume":"44","author":"J Cai","year":"2024","unstructured":"Cai, J. et al. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. Cancer Commun. 44, 1231\u20131260 (2024).","journal-title":"Cancer Commun."},{"key":"2862_CR360","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58429-7","volume":"16","author":"N Zhang","year":"2025","unstructured":"Zhang, N. et al. Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation. Nat. Commun. 16, 3177 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR361","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jhep.2024.05.007","volume":"81","author":"CX Zhu","year":"2024","unstructured":"Zhu, C. X. et al. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8+ T cells in hepatocellular carcinoma. J. Hepatol. 81, 690\u2013703 (2024).","journal-title":"J. Hepatol."},{"key":"2862_CR362","doi-asserted-by":"publisher","first-page":"e009993","DOI":"10.1136\/jitc-2024-009993","volume":"13","author":"X Wei","year":"2025","unstructured":"Wei, X. et al. Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway. J. Immunother. Cancer 13, e009993 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"2862_CR363","doi-asserted-by":"publisher","first-page":"216872","DOI":"10.1016\/j.canlet.2024.216872","volume":"591","author":"S Yu","year":"2024","unstructured":"Yu, S. et al. Tumor-associated macrophage-induced circMRCK\u03b1 encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma. Cancer Lett. 591, 216872 (2024).","journal-title":"Cancer Lett."},{"key":"2862_CR364","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55577-0","volume":"16","author":"T Lan","year":"2025","unstructured":"Lan, T. et al. The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment. Nat. Commun. 16, 333 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR365","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309298","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. M2 tumor-associated macrophages-derived exosomal MALAT1 promotes glycolysis and gastric cancer progression. Adv. Sci. 11, e2309298 (2024).","journal-title":"Adv. Sci."},{"key":"2862_CR366","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer. Signal Transduct. Target. Ther. 9, 64 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR367","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cmet.2024.11.012","volume":"37","author":"Y Fan","year":"2025","unstructured":"Fan, Y. et al. Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1. Cell Metab. 37, 514\u2013526.e5 (2025).","journal-title":"Cell Metab."},{"key":"2862_CR368","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176851","volume":"134","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation. J. Clin. Investig. 134, e176851 (2024).","journal-title":"J. Clin. Investig."},{"key":"2862_CR369","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr4458","volume":"17","author":"S Lu","year":"2025","unstructured":"Lu, S. et al. Succinate-loaded tumor cell-derived microparticles reprogram tumor-associated macrophage metabolism. Sci. Transl. Med. 17, eadr4458 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2862_CR370","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169365","volume":"133","author":"A Wang","year":"2023","unstructured":"Wang, A. et al. USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis. J. Clin. Investig. 133, e169365 (2023).","journal-title":"J. Clin. Investig."},{"key":"2862_CR371","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201217","volume":"218","author":"A Wang","year":"2021","unstructured":"Wang, A. et al. ZFP91 is required for the maintenance of regulatory T cell homeostasis and function. J. Exp. Med. 218, e20201217 (2021).","journal-title":"J. Exp. Med."},{"key":"2862_CR372","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41423-024-01229-8","volume":"21","author":"A Sharma","year":"2024","unstructured":"Sharma, A. et al. Glut3 promotes cellular O-GlcNAcylation as a distinctive tumor-supportive feature in Treg cells. Cell. Mol. Immunol. 21, 1474\u20131490 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"2862_CR373","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1016\/j.molcel.2023.10.043","volume":"83","author":"G Zhang","year":"2023","unstructured":"Zhang, G. et al. CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. Mol. Cell 83, 4370\u20134385.e9 (2023).","journal-title":"Mol. Cell"},{"key":"2862_CR374","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412109","volume":"12","author":"X Lu","year":"2025","unstructured":"Lu, X. et al. NAD+ metabolism reprogramming drives SIRT1-dependent deacetylation inducing PD-L1 nuclear localization in cervical cancer. Adv. Sci. 12, e2412109 (2025).","journal-title":"Adv. Sci."},{"key":"2862_CR375","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1016\/j.apsb.2025.07.040","volume":"15","author":"G Yang","year":"2025","unstructured":"Yang, G. et al. Succinylation of tumor suppressor PPP2R1A K541 by HAT1 converses the role in modulation of gluconeogenesis\/lipogenesis remodeling to display oncogene function. Acta Pharm. Sin. B 15, 5294\u20135311 (2025).","journal-title":"Acta Pharm. Sin. B"},{"key":"2862_CR376","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52729-0","volume":"15","author":"S Sun","year":"2024","unstructured":"Sun, S. et al. Metabolic regulation of cytoskeleton functions by HDAC6-catalyzed \u03b1-tubulin lactylation. Nat. Commun. 15, 8377 (2024).","journal-title":"Nat. Commun."},{"key":"2862_CR377","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62132-y","volume":"16","author":"T Chu","year":"2025","unstructured":"Chu, T. et al. Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma. Nat. Commun. 16, 6770 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR378","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1158\/2326-6066.CIR-24-1298","volume":"13","author":"H Zhao","year":"2025","unstructured":"Zhao, H. et al. Single-cell analysis of posttranslational modifications identifies immunosuppressive macrophage subtypes in the HBV-positive hepatocellular carcinoma microenvironment. Cancer Immunol. Res. 13, 1303\u20131317 (2025).","journal-title":"Cancer Immunol. Res."},{"key":"2862_CR379","doi-asserted-by":"publisher","first-page":"13732","DOI":"10.1073\/pnas.1704145115","volume":"114","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. O-GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect. Proc. Natl. Acad. Sci. USA 114, 13732\u201313737 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR380","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41388-019-0975-3","volume":"39","author":"JP Singh","year":"2020","unstructured":"Singh, J. P. et al. O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth. Oncogene 39, 560\u2013573 (2020).","journal-title":"Oncogene"},{"key":"2862_CR381","doi-asserted-by":"publisher","first-page":"217117","DOI":"10.1016\/j.canlet.2024.217117","volume":"598","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Histone lactylation dynamics: unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer. Cancer Lett. 598, 217117 (2024).","journal-title":"Cancer Lett."},{"key":"2862_CR382","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413445","volume":"12","author":"T Qin","year":"2025","unstructured":"Qin, T. et al. Nuclear to cytoplasmic transport is a druggable dependency in HDAC7-driven small cell lung cancer. Adv. Sci. 12, e2413445 (2025).","journal-title":"Adv. Sci."},{"key":"2862_CR383","doi-asserted-by":"publisher","first-page":"e010787","DOI":"10.1136\/jitc-2024-010787","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang, P. et al. Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. J. Immunother. Cancer 13, e010787 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"2862_CR384","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1182\/blood.2022015629","volume":"140","author":"JS Jutzi","year":"2022","unstructured":"Jutzi, J. S. et al. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood 140, 1291\u20131304 (2022).","journal-title":"Blood"},{"key":"2862_CR385","doi-asserted-by":"publisher","first-page":"1433393","DOI":"10.3389\/fimmu.2024.1433393","volume":"15","author":"L Li","year":"2024","unstructured":"Li, L., Li, W., Xiao, L. & Lai, W. Lactylation signature identifies liver fibrosis phenotypes and traces fibrotic progression to hepatocellular carcinoma. Front. Immunol. 15, 1433393 (2024).","journal-title":"Front. Immunol."},{"key":"2862_CR386","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1001\/jama.2024.4783","volume":"331","author":"E Jabbour","year":"2024","unstructured":"Jabbour, E. et al. Ponatinib vs imatinib in frontline Philadelphia chromosome-positive acute lymphoblastic leukemia: a randomized clinical trial. JAMA 331, 1814\u20131823 (2024).","journal-title":"JAMA"},{"key":"2862_CR387","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jtho.2018.09.004","volume":"14","author":"BC Cho","year":"2019","unstructured":"Cho, B. C. et al. Osimertinib versus standard of care EGFR TKI as first-line treatment in patients with EGFRm advanced NSCLC: FLAURA asian subset. J. Thorac. Oncol. 14, 99\u2013106 (2019).","journal-title":"J. Thorac. Oncol."},{"key":"2862_CR388","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam, S. S. et al. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N. Engl. J. Med. 382, 41\u201350 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2862_CR389","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1200\/JCO-24-02026","volume":"43","author":"F Pietrantonio","year":"2025","unstructured":"Pietrantonio, F. et al. Overall survival analysis of the phase III CodeBreaK 300 study of Sotorasib plus panitumumab versus investigator\u2019s choice in chemorefractory KRAS G12C colorectal cancer. J. Clin. Oncol. 43, 2147\u20132154 (2025).","journal-title":"J. Clin. Oncol."},{"key":"2862_CR390","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41586-025-09763-9","volume":"649","author":"NS Scholes","year":"2026","unstructured":"Scholes, N. S. et al. Inhibitors supercharge kinase turnover through native proteolytic circuits. Nature 649, 1032\u20131041 (2026).","journal-title":"Nature"},{"key":"2862_CR391","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202506950","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. EGFR-TKIs induced DPP4 drives metabolic reprogramming of persister cells in lung cancer. Adv. Sci. 12, e06950 (2025).","journal-title":"Adv. Sci."},{"key":"2862_CR392","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discov. 21, 141\u2013162 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2862_CR393","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41586-025-09297-0","volume":"645","author":"J Gautam","year":"2025","unstructured":"Gautam, J. et al. ACLY inhibition promotes tumour immunity and suppresses liver cancer. Nature 645, 507\u2013517 (2025).","journal-title":"Nature"},{"key":"2862_CR394","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S1470-2045(16)30375-8","volume":"17","author":"AJ Yee","year":"2016","unstructured":"Yee, A. J. et al. Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial. Lancet Oncol. 17, 1569\u20131578 (2016).","journal-title":"Lancet Oncol."},{"key":"2862_CR395","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-025-02285-w","volume":"10","author":"L Yang","year":"2025","unstructured":"Yang, L. et al. Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I\/IIb inhibitor, in relapsed\/refractory multiple myeloma and lymphoma. Signal Transduct. Target. Ther. 10, 201 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR396","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jare.2023.07.005","volume":"60","author":"MA Fischer","year":"2024","unstructured":"Fischer, M. A. et al. Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cells. J. Adv. Res. 60, 201\u2013214 (2024).","journal-title":"J. Adv. Res."},{"key":"2862_CR397","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08057-2","volume":"16","author":"X Peng","year":"2025","unstructured":"Peng, X. et al. Deacetylation of TALDO1 by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression through a moonlighting function. Cell Death Dis. 16, 743 (2025).","journal-title":"Cell Death Dis."},{"key":"2862_CR398","doi-asserted-by":"publisher","first-page":"36044","DOI":"10.1021\/jacs.5c08929","volume":"147","author":"WA Pytel","year":"2025","unstructured":"Pytel, W. A. et al. The allosteric regulator inositol phosphate dramatically affects the efficacy and selectivity of inhibitors for different HDAC complexes. J. Am. Chem. Soc. 147, 36044\u201336052 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"2862_CR399","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-025-02443-0","volume":"10","author":"T Shang","year":"2025","unstructured":"Shang, T. et al. The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer. Signal Transduct. Target. Ther. 10, 341 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR400","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s42255-020-00330-2","volume":"3","author":"W Li","year":"2021","unstructured":"Li, W. et al. NADPH levels affect cellular epigenetic state by inhibiting HDAC3-Ncor complex. Nat. Metab. 3, 75\u201389 (2021).","journal-title":"Nat. Metab."},{"key":"2862_CR401","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.cmet.2025.05.009","volume":"37","author":"T Zhao","year":"2025","unstructured":"Zhao, T. et al. Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogramming. Cell Metab. 37, 1667\u20131681.e13 (2025).","journal-title":"Cell Metab."},{"key":"2862_CR402","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1158\/2159-8290.CD-24-1033","volume":"15","author":"M Wang","year":"2025","unstructured":"Wang, M. et al. Vascular normalization augments the antitumor efficacy of combined HDAC inhibitor with immunotherapy in solid tumors. Cancer Discov. 15, 1883\u20131904 (2025).","journal-title":"Cancer Discov."},{"key":"2862_CR403","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1124\/pharmrev.122.000612","volume":"75","author":"AHM Mustafa","year":"2023","unstructured":"Mustafa, A. H. M. & Kr\u00e4mer, O. H. Pharmacological modulation of the crosstalk between aberrant janus kinase signaling and epigenetic modifiers of the histone deacetylase family to treat cancer. Pharmacol. Rev. 75, 35\u201361 (2023).","journal-title":"Pharmacol. Rev."},{"key":"2862_CR404","doi-asserted-by":"publisher","first-page":"14150","DOI":"10.1021\/acs.jmedchem.3c01242","volume":"66","author":"C Zhao","year":"2023","unstructured":"Zhao, C. et al. Discovery of novel fedratinib-based HDAC\/JAK\/BRD4 triple inhibitors with remarkable antitumor activity against triple negative breast cancer. J. Med. Chem. 66, 14150\u201314174 (2023).","journal-title":"J. Med. Chem."},{"key":"2862_CR405","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s43018-022-00489-5","volume":"4","author":"TZ Zeleke","year":"2023","unstructured":"Zeleke, T. Z. et al. Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nat. Cancer 4, 257\u2013275 (2023).","journal-title":"Nat. Cancer"},{"key":"2862_CR406","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-024-08248-5","volume":"637","author":"J Jin","year":"2025","unstructured":"Jin, J. et al. Human HDAC6 senses valine abundancy to regulate DNA damage. Nature 637, 215\u2013223 (2025).","journal-title":"Nature"},{"key":"2862_CR407","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41375-019-0517-6","volume":"33","author":"O Landgren","year":"2019","unstructured":"Landgren, O. et al. Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma. Leukemia 33, 2127\u20132143 (2019).","journal-title":"Leukemia"},{"key":"2862_CR408","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-023-01485-7","volume":"16","author":"DJ Fu","year":"2023","unstructured":"Fu, D. J. & Wang, T. Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions. J. Hematol. Oncol. 16, 87 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"2862_CR409","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1182\/blood.2022016862","volume":"141","author":"K Izutsu","year":"2023","unstructured":"Izutsu, K. et al. An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia\/lymphoma. Blood 141, 1159\u20131168 (2023).","journal-title":"Blood"},{"key":"2862_CR410","doi-asserted-by":"publisher","first-page":"e009600","DOI":"10.1136\/jitc-2024-009600","volume":"12","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors. J. Immunother. Cancer 12, e009600 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2862_CR411","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-25-1507","volume":"85","author":"K Drizyte-Miller","year":"2025","unstructured":"Drizyte-Miller, K. et al. Combination of the MTA-cooperative PRMT5 inhibitor BMS-986504 and KRAS inhibitors is an effective treatment strategy for MTAP-deleted KRAS-mutant pancreatic cancer. Cancer Res. 85, 3540\u20133557 (2025).","journal-title":"Cancer Res."},{"key":"2862_CR412","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41586-025-09299-y","volume":"649","author":"J Jeong","year":"2026","unstructured":"Jeong, J. et al. NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers. Nature 649, 205\u2013215 (2026).","journal-title":"Nature"},{"key":"2862_CR413","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49360-4","volume":"15","author":"S Figarol","year":"2024","unstructured":"Figarol, S. et al. Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies. Nat. Commun. 15, 5345 (2024).","journal-title":"Nat. Commun."},{"key":"2862_CR414","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41392-022-01248-9","volume":"8","author":"XP Tan","year":"2023","unstructured":"Tan, X. P. et al. Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression. Signal Transduct. Target. Ther. 8, 14 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR415","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41556-023-01287-6","volume":"25","author":"D McHugh","year":"2023","unstructured":"McHugh, D. et al. COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells. Nat. Cell Biol. 25, 1804\u20131820 (2023).","journal-title":"Nat. Cell Biol."},{"key":"2862_CR416","doi-asserted-by":"publisher","first-page":"9566","DOI":"10.1039\/D4SC00969J","volume":"15","author":"T Kasahara","year":"2024","unstructured":"Kasahara, T. et al. Anticancer approach by targeted activation of a global inhibitor of sialyltransferases with acrolein. Chem. Sci. 15, 9566\u20139573 (2024).","journal-title":"Chem. Sci."},{"key":"2862_CR417","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1021\/acscentsci.5c00939","volume":"11","author":"J Mou","year":"2025","unstructured":"Mou, J. et al. A potent oral sialylation inhibitor augments the immunotherapy in pancreatic ductal adenocarcinoma. ACS Cent. Sci. 11, 1969\u20131983 (2025).","journal-title":"ACS Cent. Sci."},{"key":"2862_CR418","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMoa2505725","volume":"393","author":"M Campone","year":"2025","unstructured":"Campone, M. et al. Vepdegestrant, a PROTAC estrogen receptor degrader, in advanced breast cancer. N. Engl. J. Med. 393, 556\u2013568 (2025).","journal-title":"N. Engl. J. Med."},{"key":"2862_CR419","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41586-025-09000-3","volume":"643","author":"J Zhou","year":"2025","unstructured":"Zhou, J. et al. STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity. Nature 643, 519\u2013528 (2025).","journal-title":"Nature"},{"key":"2862_CR420","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65796-8","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Discovery of a bifunctional PKMYT1-targeting PROTAC empowered by AI-generation. Nat. Commun. 16, 10759 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR421","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1021\/acs.jmedchem.1c00649","volume":"64","author":"M Zheng","year":"2021","unstructured":"Zheng, M. et al. Rational design and synthesis of novel dual PROTACs for simultaneous degradation of EGFR and PARP. J. Med. Chem. 64, 7839\u20137852 (2021).","journal-title":"J. Med. Chem."},{"key":"2862_CR422","doi-asserted-by":"publisher","first-page":"13754","DOI":"10.1021\/jacs.5c01889","volume":"147","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. USP28-based deubiquitinase-targeting chimeras for cancer treatment. J. Am. Chem. Soc. 147, 13754\u201313763 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"2862_CR423","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202518249","volume":"65","author":"C He","year":"2026","unstructured":"He, C. et al. Construction of small-molecule deubiquitinase-targeting chimeras to reactivate and stabilize mutant p53 Y220C in vitro and in vivo. Angew. Chem. 65, e18249 (2026).","journal-title":"Angew. Chem."},{"key":"2862_CR424","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1021\/jacs.2c10759","volume":"145","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. Protein phosphatase 5-recruiting chimeras for accelerating apoptosis-signal-regulated kinase 1 dephosphorylation with antiproliferative activity. J. Am. Chem. Soc. 145, 1118\u20131128 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"2862_CR425","doi-asserted-by":"publisher","first-page":"25316","DOI":"10.1021\/jacs.5c04275","volume":"147","author":"R Pergu","year":"2025","unstructured":"Pergu, R. et al. PhosphorylatIon-inducing Molecules For Regulating Dynamic Cellular Processes. J. Am. Chem. Soc. 147, 25316\u201325324 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"2862_CR426","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/acs.accounts.5c00326","volume":"58","author":"WW Wang","year":"2025","unstructured":"Wang, W. W., Singha Roy, S. J. & Parker, C. G. Targeted protein acetylation through chemically induced proximity. Acc. Chem. Res. 58, 2695\u20132707 (2025).","journal-title":"Acc. Chem. Res."},{"key":"2862_CR427","doi-asserted-by":"publisher","first-page":"9779","DOI":"10.1021\/jacs.3c14380","volume":"146","author":"B Ma","year":"2024","unstructured":"Ma, B. et al. Targeted protein O-GlcNAcylation using bifunctional small molecules. J. Am. Chem. Soc. 146, 9779\u20139789 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"2862_CR428","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41392-025-02219-6","volume":"10","author":"L Li","year":"2025","unstructured":"Li, L. et al. N-deglycosylation targeting chimera (DGlyTAC): a strategy for immune checkpoint proteins inactivation by specifically removing N-glycan. Signal Transduct. Target. Ther. 10, 139 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2862_CR429","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401142","volume":"11","author":"K Qian","year":"2024","unstructured":"Qian, K. et al. HDAC8 enhances the function of HIF-2\u03b1 by deacetylating ETS1 to decrease the sensitivity of TKIs in ccRCC. Adv. Sci. 11, e2401142 (2024).","journal-title":"Adv. Sci."},{"key":"2862_CR430","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/1878-0261.13638","volume":"18","author":"AG Kansy","year":"2024","unstructured":"Kansy, A. G. et al. Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells. Mol. Oncol. 18, 1958\u20131965 (2024).","journal-title":"Mol. Oncol."},{"key":"2862_CR431","doi-asserted-by":"publisher","first-page":"gkaf178","DOI":"10.1093\/nar\/gkaf178","volume":"53","author":"C Marx","year":"2025","unstructured":"Marx, C. et al. DNA damage response regulator ATR licenses PINK1-mediated mitophagy. Nucleic Acids Res. 53, gkaf178 (2025).","journal-title":"Nucleic Acids Res."},{"key":"2862_CR432","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/s41375-023-02036-2","volume":"37","author":"Y Zeyn","year":"2023","unstructured":"Zeyn, Y. et al. Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3. Leukemia 37, 2319\u20132323 (2023).","journal-title":"Leukemia"},{"key":"2862_CR433","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1038\/s41375-024-02405-5","volume":"38","author":"M Halilovic","year":"2024","unstructured":"Halilovic, M. et al. Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins. Leukemia 38, 2561\u20132572 (2024).","journal-title":"Leukemia"},{"key":"2862_CR434","doi-asserted-by":"publisher","first-page":"34672","DOI":"10.1021\/jacs.5c09843","volume":"147","author":"Q Zhu","year":"2025","unstructured":"Zhu, Q. et al. Enzyme-activated sugar-coated bifunctional degraders. J. Am. Chem. Soc. 147, 34672\u201334680 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"2862_CR435","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1021\/acs.jmedchem.5c00468","volume":"68","author":"Y Gao","year":"2025","unstructured":"Gao, Y. et al. GLUTs-facilitated targeting BRD4 degradation in breast cancer through carbohydrate-conjugated PROTACs. J. Med. Chem. 68, 17046\u201317064 (2025).","journal-title":"J. Med. Chem."},{"key":"2862_CR436","doi-asserted-by":"publisher","first-page":"36352","DOI":"10.1021\/jacs.5c10240","volume":"147","author":"M Serafini","year":"2025","unstructured":"Serafini, M. et al. Indolequinone-based hypoxia-activated proteolysis targeting chimeras selectively degrade BRD4 in hypoxic cancer cells. J. Am. Chem. Soc. 147, 36352\u201336364 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"2862_CR437","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202423057","volume":"64","author":"C Sun","year":"2025","unstructured":"Sun, C. et al. Enzyme-activated orthogonal proteolysis chimeras for tumor microenvironment-responsive immunomodulation. Angew. Chem. Int. Ed Engl. 64, e202423057 (2025).","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"2862_CR438","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1039\/D2CS00200K","volume":"51","author":"RG Guenette","year":"2022","unstructured":"Guenette, R. G., Yang, S. W., Min, J., Pei, B. & Potts, P. R. Target and tissue selectivity of PROTAC degraders. Chem. Soc. Rev. 51, 5740\u20135756 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"2862_CR439","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202411009","volume":"63","author":"A Guerreiro","year":"2024","unstructured":"Guerreiro, A. et al. Non-natural MUC1 glycopeptide homogeneous cancer vaccine with enhanced immunogenicity and therapeutic activity. Angew. Chem. Int. Ed. Engl. 63, e202411009 (2024).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2862_CR440","doi-asserted-by":"publisher","first-page":"9840","DOI":"10.1021\/jacs.3c02003","volume":"145","author":"SW Wang","year":"2023","unstructured":"Wang, S. W. et al. Mechanism of antigen presentation and specificity of antibody cross-reactivity elicited by an oligosaccharide-conjugate cancer vaccine. J. Am. Chem. Soc. 145, 9840\u20139849 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"2862_CR441","doi-asserted-by":"crossref","unstructured":"Engelhard, V. H. et al. MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma. J. Immunother. Cancer 8, (2020).","DOI":"10.1136\/jitc-2019-000262"},{"key":"2862_CR442","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151624","volume":"7","author":"T Dao","year":"2022","unstructured":"Dao, T. et al. A TCR mimic monoclonal antibody reactive with the \u2018public\u2019 phospho-neoantigen pIRS2\/HLA-A*02:01 complex. JCI Insight 7, e151624 (2022).","journal-title":"JCI Insight"},{"key":"2862_CR443","doi-asserted-by":"publisher","first-page":"e003526","DOI":"10.1136\/jitc-2021-003526","volume":"10","author":"RH Choudhury","year":"2022","unstructured":"Choudhury, R. H. et al. PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy. J. Immunother. Cancer 10, e003526 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"2862_CR444","doi-asserted-by":"publisher","first-page":"e001910","DOI":"10.1136\/jitc-2020-001910","volume":"9","author":"KW Cook","year":"2021","unstructured":"Cook, K. W. et al. Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy. J. Immunother. Cancer 9, e001910 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2862_CR445","doi-asserted-by":"publisher","first-page":"e000560","DOI":"10.1136\/jitc-2020-000560","volume":"8","author":"VA Brentville","year":"2020","unstructured":"Brentville, V. A. et al. Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses. J. Immunother. Cancer 8, e000560 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"2862_CR446","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000342","volume":"8","author":"CS Huang","year":"2020","unstructured":"Huang, C. S. et al. Globo H-KLH vaccine adagloxad simolenin (OBI-822)\/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study. J. Immunother. Cancer 8, e000342 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"2862_CR447","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2024.12.010","volume":"188","author":"L Zhong","year":"2025","unstructured":"Zhong, L. et al. Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients. Cell 188, 1119\u20131136.e23 (2025).","journal-title":"Cell"},{"key":"2862_CR448","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.ccell.2022.07.005","volume":"40","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy. Cancer Cell 40, 1060\u20131069.e7 (2022).","journal-title":"Cancer Cell"},{"key":"2862_CR449","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02330-w","volume":"24","author":"B Kaufman","year":"2025","unstructured":"Kaufman, B. et al. N-glycosylation of PD-L1 modulates the efficacy of immune checkpoint blockades targeting PD-L1 and PD-1. Mol. Cancer 24, 140 (2025).","journal-title":"Mol. Cancer"},{"key":"2862_CR450","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/2159-8290.CD-20-0402","volume":"10","author":"X Song","year":"2020","unstructured":"Song, X. et al. Pharmacologic suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers. Cancer Discov. 10, 1872\u20131893 (2020).","journal-title":"Cancer Discov."},{"key":"2862_CR451","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58740-3","volume":"16","author":"Y Huang","year":"2025","unstructured":"Huang, Y. et al. Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity. Nat. Commun. 16, 3546 (2025).","journal-title":"Nat. Commun."},{"key":"2862_CR452","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.1016\/j.cell.2025.09.001","volume":"188","author":"RW Zhou","year":"2025","unstructured":"Zhou, R. W. et al. Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Cell 188, 6737\u20136753.e18 (2025).","journal-title":"Cell"},{"key":"2862_CR453","doi-asserted-by":"publisher","first-page":"e01766","DOI":"10.1002\/advs.202501766","volume":"12","author":"Y Zhai","year":"2025","unstructured":"Zhai, Y. et al. Post-translational modified neoantigens in autoimmune diseases: challenges of immune tolerance. Adv. Sci. 12, e01766 (2025).","journal-title":"Adv. Sci."},{"key":"2862_CR454","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s42255-024-01093-w","volume":"6","author":"J Qin","year":"2024","unstructured":"Qin, J. et al. Ketogenic diet reshapes cancer metabolism through lysine \u03b2-hydroxybutyrylation. Nat. Metab. 6, 1505\u20131528 (2024).","journal-title":"Nat. Metab."},{"key":"2862_CR455","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409883","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Dietary palmitic acid drives a palmitoyltransferase ZDHHC15-YAP feedback loop promoting tumor metastasis. Adv. Sci. 12, e2409883 (2025).","journal-title":"Adv. Sci."},{"key":"2862_CR456","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","volume":"7","author":"M Nshanian","year":"2025","unstructured":"Nshanian, M. et al. Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression. Nat. Metab. 7, 196\u2013211 (2025).","journal-title":"Nat. Metab."},{"key":"2862_CR457","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.trecan.2024.11.003","volume":"11","author":"S Li","year":"2025","unstructured":"Li, S. et al. Short-chain fatty acids and cancer. Trends Cancer 11, 154\u2013168 (2025).","journal-title":"Trends Cancer"},{"key":"2862_CR458","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41588-025-02077-6","volume":"57","author":"L Liang","year":"2025","unstructured":"Liang, L. et al. Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma. Nat. Genet. 57, 680\u2013693 (2025).","journal-title":"Nat. Genet."},{"key":"2862_CR459","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.cmet.2024.12.007","volume":"37","author":"AT Frisch","year":"2025","unstructured":"Frisch, A. T. et al. Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapy. Cell Metab. 37, 870\u2013885.e8 (2025).","journal-title":"Cell Metab."},{"key":"2862_CR460","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-023-06061-0","volume":"617","author":"H Yuan","year":"2023","unstructured":"Yuan, H. et al. Lysine catabolism reprograms tumour immunity through histone crotonylation. Nature 617, 818\u2013826 (2023).","journal-title":"Nature"},{"key":"2862_CR461","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2407910121","volume":"121","author":"YH Cui","year":"2024","unstructured":"Cui, Y. H. et al. Targeting DTX2\/UFD1-mediated FTO degradation to regulate antitumor immunity. Proc. Natl. Acad. Sci. USA 121, e2407910121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2862_CR462","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.cmet.2024.10.019","volume":"36","author":"H Tong","year":"2024","unstructured":"Tong, H. et al. Dual impacts of serine\/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation. Cell Metab. 36, 2493\u20132510.e9 (2024).","journal-title":"Cell Metab."},{"key":"2862_CR463","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41586-024-07781-7","volume":"633","author":"H Yang","year":"2024","unstructured":"Yang, H. et al. Remodelling of the translatome controls diet and its impact on tumorigenesis. Nature 633, 189\u2013197 (2024).","journal-title":"Nature"},{"key":"2862_CR464","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","volume":"53","author":"The UniProt Consortium","year":"2025","unstructured":"The UniProt Consortium UniProt: the Universal Protein Knowledgebase in 2025. Nucleic Acids Res. 53, D609\u2013D617 (2025).","journal-title":"Nucleic Acids Res."},{"key":"2862_CR465","doi-asserted-by":"publisher","first-page":"D471","DOI":"10.1093\/nar\/gkab1017","volume":"50","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 50, D471\u2013D479 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2862_CR466","doi-asserted-by":"publisher","first-page":"D554","DOI":"10.1093\/nar\/gkae850","volume":"53","author":"X Huang","year":"2025","unstructured":"Huang, X. et al. PTMD 2.0: an updated database of disease-associated post-translational modifications. Nucleic Acids Res 53, D554\u2013D563 (2025).","journal-title":"Nucleic Acids Res"},{"key":"2862_CR467","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512\u2013D520 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2862_CR468","doi-asserted-by":"publisher","first-page":"D261","DOI":"10.1093\/nar\/gkq1104","volume":"39","author":"H Dinkel","year":"2011","unstructured":"Dinkel, H. et al. Phospho.ELM: a database of phosphorylation sites-update 2011. Nucleic Acids Res. 39, D261\u2013D267 (2011).","journal-title":"Nucleic Acids Res."},{"key":"2862_CR469","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/glycob\/cwz080","volume":"30","author":"WS York","year":"2020","unstructured":"York, W. S. et al. GlyGen: computational and informatics resources for glycoscience. Glycobiology 30, 72\u201373 (2020).","journal-title":"Glycobiology"},{"key":"2862_CR470","doi-asserted-by":"publisher","first-page":"D451","DOI":"10.1093\/nar\/gkab849","volume":"50","author":"W Zhang","year":"2022","unstructured":"Zhang, W. et al. CPLM 4.0: an updated database with rich annotations for protein lysine modifications. Nucleic Acids Res. 50, D451\u2013D459 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2862_CR471","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/pmic.200300771","volume":"4","author":"N Blom","year":"2004","unstructured":"Blom, N., Sicheritz-Pont\u00e9n, T., Gupta, R., Gammeltoft, S. & Brunak, S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4, 1633\u20131649 (2004).","journal-title":"Proteomics"},{"key":"2862_CR472","doi-asserted-by":"crossref","unstructured":"Gupta, R. & Brunak, S. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac. Symp. Biocomput. 310\u2013322 (2002).","DOI":"10.1142\/9789812799623_0029"},{"key":"2862_CR473","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1093\/bioinformatics\/bti130","volume":"21","author":"L Kiemer","year":"2005","unstructured":"Kiemer, L., Bendtsen, J. D. & Blom, N. NetAcet: prediction of N-terminal acetylation sites. Bioinformatics 21, 1269\u20131270 (2005).","journal-title":"Bioinformatics"},{"key":"2862_CR474","doi-asserted-by":"publisher","first-page":"W238","DOI":"10.1093\/nar\/gkae346","volume":"52","author":"Y Gou","year":"2024","unstructured":"Gou, Y. et al. GPS-SUMO 2.0: an updated online service for the prediction of SUMOylation sites and SUMO-interacting motifs. Nucleic Acids Res. 52, W238\u2013W247 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2862_CR475","doi-asserted-by":"publisher","first-page":"W243","DOI":"10.1093\/nar\/gkad383","volume":"51","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. GPS 6.0: an updated server for prediction of kinase-specific phosphorylation sites in proteins. Nucleic Acids Res. 51, W243\u2013W250 (2023).","journal-title":"Nucleic Acids Res."},{"key":"2862_CR476","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.gpb.2020.01.001","volume":"18","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. GPS 5.0: an update on the prediction of kinase-specific phosphorylation sites in proteins. Genomics Proteomics Bioinform. 18, 72\u201380 (2020).","journal-title":"Genomics Proteomics Bioinform."},{"key":"2862_CR477","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/bib\/bbaa038","volume":"22","author":"W Ning","year":"2021","unstructured":"Ning, W. et al. GPS-Palm: a deep learning-based graphic presentation system for the prediction of S-palmitoylation sites in proteins. Brief. Bioinform. 22, 1836\u20131847 (2021).","journal-title":"Brief. Bioinform."},{"key":"2862_CR478","doi-asserted-by":"publisher","first-page":"D767","DOI":"10.1093\/nar\/gkn892","volume":"37","author":"TS Keshava Prasad","year":"2009","unstructured":"Keshava Prasad, T. S. et al. Human Protein Reference Database-2009 update. Nucleic Acids Res. 37, D767\u2013D772 (2009).","journal-title":"Nucleic Acids Res."},{"key":"2862_CR479","doi-asserted-by":"publisher","first-page":"D542","DOI":"10.1093\/nar\/gkx1104","volume":"46","author":"H Huang","year":"2018","unstructured":"Huang, H. et al. iPTMnet: an integrated resource for protein post-translational modification network discovery. Nucleic Acids Res. 46, D542\u2013D550 (2018).","journal-title":"Nucleic Acids Res."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02862-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02862-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02862-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:01:29Z","timestamp":1786060889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02862-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":479,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2862"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02862-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"314"}}